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The work described in this thesis was conducted between 
October 1981 and September 1984 and is concerned with the 
synthesis of endophosphonopeptides as possible transition 
state surrogates.
Various coupling methods for phosphonamide formation 
have been studied and several N-protecting functionalities 
evaluated in our synthetic strategy. The synthesis of an 
endophosphonoenkephalin an analogue of the naturally 
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Structural variants of biologically important peptides 
are attracting increasing attention in the search of chemo- 
therapeutically useful drugs. This research programme was 
concerned with the synthesis of peptide analogues in which 
key amide linkages were replaced by phosphohamide (1). The 
Object was to synthesise endophosphonamide transition state 
surrogates for the cleavage of scissile peptide bonds.
NH—
OR
(1) R = H or Alkyl
II. Synthesis of a-aminophosphonic and a-aminophosphinic acids
A range of synthetic routes to a-aminophosphonic acids
has been developed, but novel strategies are necessary as
emerging data points to their potential use as chemical regulators
of biological mechanisms. The synthesis of a-aminophosphjoic
acids has been previously reviewed^ and Redmore has published a
2comprehensive review of the chemistry of P-C-N systems.
A. Mannich type procedures
3Many such examples have been reported in the literature . 
The reaction is that in which a phosphorus species has replaced 
the carbon nucleophile of the normal Mannich reaction. In 1952
2.
4
Kaoachnik and Medved described the first synthesis of
a -aminophosphonic acids from readily available starting
materials, employing the reactions of aldehydes with ammonia
5and dialkylphosphites. Subsequently they showed that a 
similar reaction occurred with ketones. The general reaction 
can be represented as :
RgOgPH + R^R^CO + NHg' ^R^O^PCOXR^ )(R^ )NH2
The methodology was further developed by improving yields 
and establishing conditions for hydrolysis of the phosphonate 
ester.^ Fields^ has investigated the mechanism of this reaction 
and showed that a-aminoalcohols yielded a-aminophosphonates 
on treatment with diethylphosphite. It was therefore suggested
that a-aminoalcohols are likely intermediates in this process.
Phosphorous acid, formaldehyde and amines heated under 
strongly acidic conditions afforded good yields of a-amino- 
methylphosphonic acid.
The procedure, originally described by Moedritzer and Irani ^ 
may oe represented by the equation;
R^ NH + nCILO+ nHPO_H^ »R_ N (C H ^PO .H ^) + nH^O3-n n L 3 2 3-n 2 3 2 n 2
However, the method is limited. Primary amines treated with 
one equivalent of formaldehyde and phosphorous acid yielded mixtures 
of mono- and di-phosphonic acid derivatives. With one exception,
9in the patent literature , formaldehyde has been the choice of
3.
carbonyl component. Redmore^^ prepared several a-aminoaryl 
phosphonic acids by this procedure using arylaldehydes as the 
carbonyl components.
Polish workers ^ reported that phosphorous acid and 
benzylamine reacted with a range of carbonyl compounds, 
including acetone, propionaldéhyde, and methyl ethyl ketone, 
affording the corresponding a-aminoalkylphosphonic acids. 
Reinvestigation of this work demonstrated^^ that the products 
exhibited different physical properties to authentic samples 
prepared by alternative routes.
2
Redmore suggested a mechanism (Scheme 1) which was 
consistent with the experimental observations.
4"
R^NH + CHgO -----^ R^NCHgOH  > R^N = CH^-------- > R^NCH^PO^H^
(2) (3) (4)
(Scheme 1)
Thus, the amine reacted with formaldehyde to give the 
ot-aminoalcohol (2 ) which subsequently eliminated water giving 
the iminium ion (3), and reaction with phosphorousacid yielded 
a -aminomethylphosphonic acid (4).
4.
B. Addition of Phosphorus Nucleophiles to Caroon-Nitrogen 
Double Bonds.
Numerous examples of this procedure are described in the
3
literature , and a range of substrates may oe used. Aspects
of the addition of phosphorus esters to unsaturated systems
12have been reviewed. The following examples were selected to
indicate the generality of this methodology.
1. Imines
It has been shown^^'^^ that dialkyl phosphites added to 
imines in the presence of a catalytic amount of sodium ethoxide, 
Phenylphosphinates may be prepared in an analogous fashion from 
alkylphenylphosphonites^^ (Scheme 2),












The reaction of diethylphosphite and N-methylene-t-outyl amine
(5) gave an a-aminophosphonate (6)^^, which was hydrolysed to 
the free a-aminophosphonic acid (7),
5.
' b u N=CHj (r'o ^ ^ nhr^
(6) = Et, = t(5) Bu
(7) R^ = R^ = H
Imine derivatives have been prepared with nitrogen protection
that may be readily removed from the final product. Thus,
17the use of benzylamine in the formation of the imine led to 
an N-benzyl- a-aminophosphonate. The free base was obtained 
upon catalytic hydrogenation (Scheme 3).
RCHO + P h -^ N H  ------ > R - ^ N - ^ P h
N H ^ P hX
i, (Rlo)gPOH
(Scheme 3).
Derivatives in which alkyl substituents attached to the oenzyl
methylene gave products in which the amine functionality was
18 19 20more readily deprotected. ’ ’ Diphenylmethylcumin& was
21used to prepare a-aminophosphonic and a -aminophosphinic 
22acids containing a benzhydryl protected amino functionality 
which could be cleaved under mild conditions.
6.
23Both enantiomers of a-aminooenzylphosphonic acid (9) 
were obtained using the dialkyl phosphite-imine approach.
If either R'( + )- or S(-)-2-methylDenzylamine (8) were employed 
an optically active a-aminooenzylphosphonic acid (9) was 
Obtained (Scheme 4).
PhCHO + P h /|^ N K  ---------
A ^ !
(8)
PhCHPOEt I 3 2 





Imines derived from carbohydrates reacted with dialkyl










i. PhCH^NH^; ii,(RO)^^H; iii, U^/Pd; iv, HBr/HOAc.2 2 
(Scheme 5).
Reactive N-fluorosulphonyl intermediates (10) and dialkyl 
25phosphites reacted giving good yields of the a-aminophosphonate 
and thence the corresponding ot-aminophosphonic acid.
RCH=NSOF 2
(10)
26The reactions of 1,3,5-trioenzylhexahydrotriazine (11) and 
27pyrroline trimer (12) with dialkyl phosphites were postulated 
















Thus (11) and (12) acted as precursors to imines (13) and (14)
and reacted with diethyl phosphite giving a-aminophosphonates
28(15) and (16) respectively. Just described an expedient
route from (17) to (18), an important intermediate in the 
29Merck synthesis of cephalosporins.
C O ^ R
N - ^ P h
C O g R
H N /^ P O E t  2 3 2
(17) (18)
9.
2. Aldazines and Ketazines
The reaction of aromatic aldazines with dialkyl
phosphites^^'^^'^^ and alkyl phosphites gave a-amino-
phosphonates and a-aminophosphinates respectively (Scheme 7).
Similarly aliphatic aldazines gave a-aminoalkylphosphonates^^’
36and G-aminoalkylphosphinates
PhCHzzN—N=CHPh Ph ^NH—N H \^ P h
»  R P O R ^  
2
“ o r '  2
1 ,11,111
NH2 = OEt, O^Pr, Me, Et, Pr
2 iR = Et, Pr
i, Na cat; ii, HCl-AcOH; iii, propylene oxide
(Scheme 7)
37A ketazine was employed in an analogous reaction. Thus, 
cyclopentanone ketazine (19) led to a-aminophosphinic acid 









R = Et, Me
R = OMe, Me
i, Hg-Ni; ii, HCl-AcOH; iii, propylene oxide
(Scheme 8)
3, Isothioacetamides
Nitriles were employed in a route to 1,l-dialkyldiphospho.nic 
38acids but have not, until recently, been used to prepare
a-aminophosphonic acids. N-Carboxy-S-methyl-iso-thioacetamide
39(21) uxxsprepared oy heating acetonitrile with methanethiol
under acidic conditions. Reacting the product with ethyl
chloroformate to give (21) further elaboration of which yielded
a-aminophosphonic acid (22) (Scheme 9). This procedure was








i, NaPOgEt^; ii, H^-Ni; iii, HBr; iv, propylene oxide 
(Scheme 9)
4. Nitrones
The addition of dialkyl phosphites to nitrones led to
an asymmetric synthesis of four a-aminoalkylphosphonic 
41acids (Scheme 10).
Treatment of diethyl or dimethyl phosphite with nitrone
(24), prepared in situ from the oxime (23) and formaldehyde, 
gave (N-glycosyl)hydroxyaminophosphonates (25) and (26) in 
excellent yields. Oxidation of (25) and (26) in the presence 
of ethene afforded the cycloadducts (27 - 30) in a 1:1 
ratio. Stereochemical assignments of the cycloadducts 
were made by comparing the proton NMR spectra and specific 
rotations of the diacetates (31) and (32) with those of the 
corresponding a-amino acid derivatives of known configuration.
12.
(23) (24)
"  H O - '
(25) R = Et









POgEt^, R = H
H, R^ = PO^Etg
1 2(29) R = POgMe^, R = H
1 2(30) R = H, R = POgMeg
(Scheme 10).
13.
The results Indicated preferential formation of the L-isomers. 
Subsequently (30) and (32) were transformed into aminophosphonic 
acid analogues of L-5-oxaproline, L-homoserine, L-aspartic 
acid and L-asparagine.
C. Procedures which occur via Michaelis-Becker or 
Arbuzov Reactions 
The Michaelis-Becker reaction in which a dialkyl phosphite, 
alkyl phosphonite or phosphonite anion is used to displace a 
halide from an alkyl halide compl^ents the Arbuzov reaction.
42An interesting example is the preparation of 
N,N-diethyl-2-aminophosphonate (33) (Scheme 11). In this case 
the Arbuzov reaction yielded only the dimerised amine (34) 





i, P(OEt)g, ; ii, NaPO^Et^, RT. (33)
(Scheme 11).
14.
Squibb researchers^^ prepared optically active 2-aminoalkyl- 
phosphonic acids by displacing an O-tosyl group with sodium 
dialkylphosphonates or sodium alkylphosphinates.
1. Arbuzov Reaction with Alkyl Halides
44, 45The Arbuzov reaction ’ in which a trivalent phosphorus
ester reacts with an alkyl halide, is one of the principal
synthetic methods for the formation of carbon phosphorus bonds,
The process involves a valency expansion of phosphorus and the
driving force for the reaction is the formation of the very
— 1strong phosphonyl P=0 bond (627 kJ mol ).
Arbuzov reactions of N-bromomethylphthalimide (35) with
phosphites or phosphonites gave a-aminomethylphosphonic (36)
46and a-aminomethylphosphinic (37) respectively (Scheme 12).
(36) R = OH
(37) R = Me
i, heat; ii, HBr-AcOH 
(Scheme 12).
15.
The synthesis of a-aminophosphonates and &-amino- 
phosphinates by this procedure is somewhat limited by the 
availability of the requisite halide.
2, Arbuzov Reactions with Acyl Halides
Trialkyl phosphites readily react with acyl halides
47producing acyl phosphonates . In one of the first syntheses
48
of a-aminophosphonates Kosolapoff prepared diethylbenzoyl- 
phosphonate. After conversion to its p-nitrophenylhydrazone, 
*if*w.os r e u s i n g  aluminium-amalgam.
More recently it has been observed that dialkyl aroyl
phosphonates and dialkyl acylphosphonates (38) may be converted
to the corresponding oximes by treatment with hydroxylamine 
49hydrochloride . Reduction of the aryloximes with aluminium- 
amalgam afford a-aminoarylphosphonates (39, R = aryl) and 
reduction of the alkyl oximes using Raney nickel gave a-amino- 
alkylphosphonates (39, R* = alkyl). (Scheme 13).
(R O ^ P  +  F k ^ C l  ------------- >
(38) R = Et






A procedure was devised in which acylphosphonates were
50converted to their 0-methyl oximes , reduction of which to
a-aminoalkylphosphonates was achieved with diborane. This
approach was employed^^ in a synthetic route to several
a -aminophosphonic acids, including some analogues of naturally
occurring amino acids. Acylphosphonates have also been 
52converted to a-aminoalkylphosphonic acids via the corresponding 
hydrazones.
3. Arbuzov Reaction and Michaelis-Becker Reactions of
g,g -Unsaturated compounds
53Chambers and Isbell used acetamidoacrylic acid (40) in 
an Arbuzov reaction to obtain the aspartic acid analogue (41). 
Subsequently, the procedure was improved^^ and the use of diethyl 
acetamidomethylenemalonate (42), giving a further analogue of 
aspartic acid (43) was described. (Scheme 14).
Pyrrolidine enamine (44) reacted with diethyl phosphite
to give g-aminophosphonate (45). It was noted that the
corresponding enamine hydrochloride reacts with sodium diethyl




F T  ,0 ,COB 
^ N H C O M .
2(40) (41)
HCOMe





ii, HCl-HgO, 100°; iii, NaOEt
(Scheme 14 ).
18.
4. Isothiocyanates in Arbuzov Reactions
56The preparation of N-ethoxycarbonylisothiocyanate 
has been described. Subsequent addition of trimethyl 
phosphite gave 0,0-dimethyl-l-(N-ethoxycarDonylimino)-l- 
thiomethyl methylphosphonate.
57In a similar reaction with triethyl phosphite, 
phosphonate (46) was obtained. Grignard reactions gave, 
after reductive desulphurisation and hydrolysis, 
alkylmethylaminophosphonic acids, (47).
In contrast, imido chloride (48), ootained oy treating 
(46) with thionyl chloride, reacted with Grignard reagents 
to give mono- and dialkyl addition products (49) and (50) 












t i •POEt 3 2
I 11,111






i, RMgX; ii, NaBH ; iii, HBr; iv, SOCl^
(Scheme 15).
20.
5, Other Arbuzov Reactions
Reaction of trimethyl or triethyl phosphite with 
(N-phenylbenzimidoyl)-formic acid (51) generated the 





59N-Substituted aziridines react with trimethyl phosphite 
under acidic conditions to give a-aminophosphonates. The 
authors suggested that treatment of the aziridine with acid 
afforded an equilibrium mixture of intermediates and that the 
trimethyl phosphite reacted with an iminium species (53) 
producing a-aminophosphonate (54) via an Arbuzov type reaction 
(Scheme 16). C 0 M 8




i, PhOOgH; ii, P(OMe)
(Scheme 16),
21.
Campbell and C a r r u t h e r s ^ ^ ' explored a quasi-Arbuzov 
reaction in acetate displacement from 4-acetoxyazetidin-2-one, 
Obtaining a range of 4-oxoazetidin-2-ylphosphonates and 




" ' r '
(55)
R Me Et CHsPh Et CH^Ph CH^CClg Et
OMe OEt OOHgPh Me Me Me C CPh
i, P(OMe)^
( Scheme 17 ).
These internally-protected a-aminoacids were then 
converted into phosphonoaspartic acids.
Displacement of acetate from (56) in a quasi-Arbuzov
process, using triphenyl phosphite led to (57) and thence
62to diphenylphosphonoglycine
22.
P h ^ X ) ^ ^ H / ^ O A c
(56) (57)
A new strategy involved formation of an acyliminium ion 
(59) from (58) by electrochemical means^^. Trapping of (59) 
by phosphites yielded substituted aminophosphonic acids (60),





1 2R , R = H, alkyl, cycloalkyl.
D, Rearrangement Reactions 
1. Curtius Reaction
64The Curtius rearrangement has been employed by Isbell 
for the synthesis of a-aminophosphonic acids. Thus ethyl 
bromoalkanoates, (61) with triethyl phosphite, gave the 
diethylphosphonate (62) in an Arbuzov reaction. Treatment of 
phosphonates (62) with excess hydrazine afforded hydrazides (63) 
which were converted to the isocyanates (65) via acyl azides (64).
23.
Hydrolysis of the isocyanates (65) either directly or via 







i, P(OEt)^; ii, H^NNH^; iii, HCl, NaNO^; iv, EtOH; v, HCl.
R Me Et CHsPh ^Pr ^Pr ” bu *Hex "Dec Ph Me
H H H H H H H H H Me
(Scheme 18).
24.
A recent application of the Curtius rearrangement may oe 









1, (PhO) PON ; ii, PhCH OH; iii, HCl
(Scheme 19)
2, Hofmann rearrangement
Two groups have applied the Hofmann rearrangement to the
66synthesis of a-aminophosphonic acids. Whilst Rachon only 
isolated a-aminophosphonic acids as products (Scheme 20).
CONH„
i , i i , U l
N H .
n.R = Me, Et, Pr, Ph
i, KOH, Brgi ii, HCl-AcOH; iii, propylene oxide.
(Scheme 20).
25.
67Saroka and Mastalerz found that the course of the reaction 
was dependent on the structure of the phosphonoacetamide 
starting material. Thus in only two instances was a Hofmann 
rearrangement observed. In other examples a-brominated 
products were formed. The parent phosphonoacetamide gave a 
mixture of dibromoacetamide (69) and dibromoacetic acid (70) 
(Scheme 21).















i, NaOBr-2K NaOH; ii, HCl; iii, 2N NaOH 
(Scheme 21).
26.
E, Other Methods of Preparing a-Aminophosphonic and 
g -Aminophosphinic Acids
1. Phosphorus trichloride
One of the earliest preparative methods for a-amino-
68phosphonic acids utilised phosphorus trichloride . Treatment 
of the g-hydroxyamide (71) with phosphorus trichloride and 
acetic acid, followed by hydrolysis, gave g-aminophosphonic 
acid (72).
0
r7^35^ H H ^ 1 4 ^  PÔ Ĥ
(71) (72)
This method required long reaction times (12 hours to 7 days)
and, consequently, phosphorus trichloride had not generally
been exploited in the synthesis of a-aminophosphonic acids.
One-pot procedures for the preparation of g -aminophosphonic,
69a-aminophosphinic acids N-alkyl-g -aminophosphonic and
70N-alkyl- ^-aminophosphinic acids have now been described 
(Scheme 22).
27.
0 PCI + PhCHpCONH
3 2 2 FT POH
o  ^
R ^ P O
R Me Ph Me
R H H Me
RCHO 4- RPCl + PhCHOCONHR^^^
2 2 Y " - o h
NHR
R Me Et Me iPr Ph Me Ph
1R H H H H H H H
2R Ph Ph Et Et Et Me Me
4- RPCl + PhCHOCONH -  
2 2 2 P — R "  
B ^ O H
R Me Me Me "pr Me Me Me Me ^Pr
R^ Cl Cl Cl Cl Cl Ph Ph Ph ?n
R^ Me ”pr ^Pr PhCHg ° S " l l Me ^Pr ^Pr Me
i, AcOH; ii, HgO
(Scheme 22).
28.
To date this method is one of the simplest for the preparation
of free or N-alkyl substituted a-aminophosphonic or
a-aminophosphinic acids. A notable application of this
procedure is to be found in the synthesis of phosphonic and
70phosphinic analogues of proline (73) (Scheme 23).
(73)
i, PhCHgOCONHg; ii, RPCl^; iii, AcOH; iv, HCl-H^O; v, NaOH
(Scheme 23).
However, this reaction is limited to aldehydes and 
carbamates derived from primary amines. Efforts to extend the 
methodology to ketones and benzyl-N,N-dialkylcarbamates have 
been unsuccessful
2. Phosphorous Acid
Apart from its use in Mannich type reactions phosphorous 
acid has also been utilised in other routes to afford a-amino­
alkylphosphonic acids. Amidoalkylation of phosphorous acid
72yielded a-aminoalkyl and a-aminoarylphosphonic acids 
Phosphorous acid, amides and aldehydes reacted in acetic anhydride 
giving N-acylated a-aminophosphonic acids (Scheme 24).
29.
RCHO + R C O N H + Ĥ PO 1 -AcOH V POH3 2
NHCOR
R Me Me iPr S-NO^CgH^ 4C1C_H. 4-MeC_H, 6 4 6 4
1R PhCHgO Ph PhCHgO Me Ph Me Ph
(Scheme 24).
Patents described the conversion of a carboxylic acid into its
phosphonic acid analogue using mixtures of phosphorous acid and
73 T4phosphorus trichloride . Also mentioned was the conversion
75of nitrilotriacetic acid to its phosphonic acid analogue (74) .
More recently, the method was extended to N,N-dibenzylglycine 
which gave aminomethylphosphonic acid (72)76 ,
H N C H P O ^ j
(74)
(72)
The preparation of aminomethylphosphonic acid by treating 
a mixture of phosphorous acid and trioxane in acetonitrile with 
phosphorus trichloride has been described in the patent 
literature .
30.
3. Use of Urea and Thiourea Derivatives.
78The discovery by Birum that urea and many mono- and 
di-substituted ureas and thioureas reacted with aldehydes 
and trivalent phosphorus esters giving a-ureidophosphonates, 
led to the development of a novel route to a-aminophosphonic 
acids. The reaction of urea with triphenylphosphite produces 
both diphosphonate (75) and monophosphonate (76). However, 
mono- and di-substituted ureas (77) and (78) gave only mono- 
phosphonates (79) and (80) respectively. Phosphonite esters 
were also found to react in a similar manner giving ureido- 
phosphonates (Scheme 25).
gHNCONH +- PtoPh^ + CĤ CHO >  ( P h C » R
(75)















2 ^  2
(80)
31.
Ali interesting observation was that triaryl phosphites 
were more reactive than trialkyl phosphites as trialkyl 
phosphites required acid catalysis before reaction occurred.
A reversal in the order of reactivity was explained oy the 
mechanism shown in Scheme 26. The first step in the formation 
of ureidophosphonates was the acid-catalysed reaction of urea 
and the aldehyde. Trialkyl phosphites are basic enough to 
inhibit the first step whereas the less basic triphenyl phosphite 
does not lower the acidity below the level needed for the reaction 
of the urea with the aldehyde.
OH 0
RCHO + HNCONH^— — > ^
2




Several applications of this procedure in the synthesis of
a-aminophosphonic acids have appeared. Birum's reaction
sequence was modified by hydrolysis of a ureidophosphonate 
79(81) (Scheme 27). More recently the reaction sequence was used
80to prepare both enantiomers of a*-aminobenzylphosphonic acid . .




i, BFg-EtgO; ii, HCl-AcOH; iii propylene oxide,
(Scheme 27).
Kudzin and Stec have elaborated earlier work with thioureas
providing a "one-pot" synthesis of a-aminoalkylphosphonic
81acids via the thioureidoalkane phosphonates . The method was
applied to the syntheses of phosphonic acid analogues of


















More recently, isolation of the free thiols (86) and (87)
via their mercury salts has been described^^, (Scheme 28),
85An identical sequence was employed to prepare phosphonic 
acid analogues of homocystine, methionine and ethionine.
34.















Reaction of triphenyl phosphite with benzyl carbamate
86gave either diphenylaminoalkylphosphonates (88) or the
87corresponding free phosphonic acids (89) depending on 
the method of hydrolysis (Scheme 29),







i, AcOH; ii, HBr-AcOH; iii, NH -Et^O; iv, HCl
(Scheme 29).
36.
5. Halomethyl Phosphorus Species
Nucleophilic displacement reactions on halomethylphosphorus
species have received little attention, probably because of the
difficulties associated with the desired displacement.
88Kosolapoff prepared 1-methyl-l-phenyl-l-aminophosphonic acid
(91) in low yield from the corresponding chloro-compound (90).
OH,
(90) (91)
89,90,91Subsequently Medved used diethylhalomethylphosphonates
to prepare the phosphonic analogue of glycine (92).
/O H  
0
(92)
Reaction of chloromethylphôsphonic acid with primary
amines in the presence of sodium hydroxide was employed to
Obtain a-aminophosphonic acid derivatives for use as chelating 
92 93agents  ̂ . However, these methods did not yield products in
which the substituents on the amino group could be easily removed,
37.
6. Hydroxymethyl Phosphorus Precursors.
The Mitsunubo reagent was utilised in a mild conversion
94of ot-hydroxyphosphonates (93) to a-phthalimidophosphonates (94)
A useful synthesis of a-phthalimidophosphonates has recently 
95been described
OH ÿFt
R^POEt R ^P O E t
3 2 3 2
(93) (94)
III a-Aminophosphonic and a-Aminophosphinic Acid analogues of 
the naturally occurring a-amino acids.
The a-aminophosphonic and a-aminophosphinic acid 
analogues of the naturally occurring a-amino acids that have 
been synthesised to date are represented in Table 1.
38.
Table 1.
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42.
IV Phosphonic and Phosphinic Acids of Biological Interest.
Many phosphonic and phosphinic acids of natural and 
synthetic origin have Been shown to exhibit biological activity, 
They may act as antibiotics, transition state analogues and 
enzyme inhibitors. Some of the more important phosphonic and 
phosphinic acids of biological interest are discussed,
A, Phosphonic acid antibiotics
The isolation, structure elucidation and antibacterial
properties of five new phosphonic acids antibiotics were
114described by Fujisawa Laboratories , FR-900098 (95),
FR-31564 (96), FR-33298 (97), FR-32863 (98) and FR-900137 (99) 





(95) R = Me, X = H
(96) R = H, X = H
(97) R = Me, X = OH
HN
2 j 3 2 
Me
(99)
The activity of all five antibiotics was associated with cell 
wall growth. Compound (99) exhibited Gram positive and negative 
activity whereas compounds (95) to (98) exhibited broad spectrum
43.
Gram negative activity. Syntheses of (95) to (98) have been 
reported^^^. The phosphazacins A and B (100) and (101)^^^ 
have unique structures, antibiotic activity and resemble the 







(100) R = H
(101) R = C0CH(NH2)iPr
117Phosphonomycin (1B2) (-)(1R, 2 8 )-l,2-epoxypropylphosphonic
acid) isolated from Streptomyces fradia was active against gram
positive and gram negative bacteria. Its mode of action involved
irreversible binding to the enzyme pyruvate uridine diphospho-N-
acetyl glucosamine, thus inhibiting cell wall biosynthesis.
118The analogue (103) an azridinylphosphonic acid was also 
thought to possess antimicrobal activity.
H H H ^






119(104) isolated at Hoffman-La Roche from a Streptomyces 
species was active against gram positive and gram negative 




B. Other biologically active phosphonic and phosphinic acids
N-Phosphonoacetyl-L-aspartate (PALA) (105, Scheme 30)
is a transition state analogue for aspartate transcarbamylose 
120Its synthesis was rationalised on the basis that a stable
surrogate for the transition state could be a specific and
potent enzyme inhibitor. It was found that (105) bound to
aspartate transcarbamylose one thousand times more strongly
than carbamyl phosphate. PALA (105) has shown considerable
121activity against certain transplantable tumours in mice 














122Glyphosate , N-(phosphonomethyl)glycine (106) is a
123 124unique post-emergence herbicide. Its mode of action ’ 
is due to inhibition of the biosynthesis of aromatic amino acids
H O P -^N H  -^ C O H
(106)
46.
125APD , 3-Amino-l-hydroxypropyl-l,1-diphosphonic acid (107) 
has found application in the treatment of Paget's disease, a 
chronic, progressive disorder characterized oy bone softening 
and increased skeletal deformation.
(107)
Phosphonoacyl compounds active against herpes simplex virus
have been produced. Phosphonoformate (PFA), phosphonoacetate
(PAA) and phosphonopropionate (PPA) (108) are less highly
cytotoxic than the standard antiviral compounds idoxuridine and
vidOfabine. They are competitive inhibitors of pyrophosphate
during the herpes virus induced DNA polymerase reaction, and
126bind to the enzyme at the pyrophosphate binding site
(108)
n = 0, PFA 
n = 1, PAA 
n = 2, PPA
127The tetrazole analogue (109) showed greater inhibition of 
herpes simplex II than PAA, but lower inhibition of type I 
than PAA.
47.
V. Biologically Active peptides with a terminal
Phosphonic or phosphinic acid
Plinnbemycins A and B (110) were isolated from 
128Streptomyces plurobeus and assigned L-alanyl-L-aspartyl- 
D-2-amino-5-phosphono-3-cis-pentanoic acid and L-alanyl-L- 
aspar&ginyl-D-2-amino-5-phosphono-3-cis-pentanoic acid 
respectively. Both antibiotics are threonine antagonists and 
are transported into bacterial cells via the oligopeptide




R = COgH, Plumbemycin A.
R = CONHg, Plumbemycin B
The antibiotic Phosphinothricin, Phosphinothricyl-alanyl-alanine
130(111) was isolated from Streptomyces hygroscopicus and
131Streptomyces viridochromogenes . It is highly active
against gram positive and gram negative bacteria and is a
129possible glutamine synthetase inhibitor , entering via 







The novel, 2-amino-4-met&ylphosphinohutanoic acid
component (112) of the tripeptide (111) is itself a herbicide,
which possibly inhibits glutamine synthetase. It was 
131synthesised (Scheme 31) by radical addition of a methyl- 
phosphonite to acrolein acetal (113) followed by hydrolysis
of (114) and Strecker reaction of (115). Other syntheses
131 132started from homoserine , acetylaminomalonate and from
133a-propionaldehyde acetals . A recent and different 
synthetic strategy (Scheme 32) employed a vinyl phosphonate 
which was transformed via a Michael reaction to (+)-phosphino- 
thricin in good yield^^^. The isolation of bialaphos (116), 
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(117) is a synthetic antibacterial agent prepared by Roche,
designed to mimic the terminal peptide moiety (D-alanyl-D-
alanine) of the peptidoglycan involved in bacterial cell wall
biosynthesis. The mode of action is thought to involve three 
136stages
1. transport through the bacterial cell wall by 
peptide permeases ;
2. intracellular peptidase cleavage; and
3. action of the L-l-aminoethylphosphonic acid on alanine 
racemaJTe.
HN•VN H ^ P O -H32
(117)
Alaphosphin has greater effect against gram negative than
gram positive bacteria. A range of derived and related
137phosphonopeptides have also been described
51.
VI Peptides containing a phosphoramidate moiety
Phosphoramidon, N-( ot-L-rhamnopyranosyloxyhydroxy-
phosphinyl)-L-leucyl-L“tryptophan) (118) has been isolated from
Streptomyces tanashiensis and shown to be a potent inhibitor of
138the thermostable metalloprotease thermolysin . Fig, 1 shows
a schematic representation of the interactions observed in the
139
phosphoramidon-thermolysin complex. A series of N-phosphorylated
140dipeptides and amino-acid derivatives were synthesised . These 
compounds which are analogues of phosphoramidon were shown to be 
competitive inhibitors of thermolysin,
c> 1 ^
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VII Endophosphonopeptides;- Peptide Analogues containing a 
phosphonamide bond
Dipeptide analogues linked with a phosphonamide oond were 
produced by the reaction of C-protected amino acids with 
N-protected aminophosphonomonochloridates^^^'142,143^
141 142Japanese workers and others coupled N-phthaloyl
aminophosphonomonochloridates with amino acid esters, producing
the dipeptide analogues (119) and (120) (Scheme 33). The
Japanese group extended this methodology leading to a synthesis
141,14 2of tripeptides containing aminomethylphosphonic acid
No biological data on these protected peptide analogues was
reported.
Recently the activation of N-protected aminophosphonic 
acids using diphenylphosphorylazide (DPPA) was described in the
synthesis of peptide analogues containing (2-Aminoethyl )
.^145 phosphonic acid
143Bartlett synthesised the endophosphonodipeptide (121) 
by coupling the N-benzyloxycaroonyl protected aminophosphono- 
monochloridate with phenylalanine methyl ester (Scheme 34).
54.
FtN \^P O ^E t^ — Ft N^/ PO^Et Cl  “  - >
Ph Ph
F t N ^/CO ^Et
PhOEt
(119)
11F tN ^ P O iP r - ^  FlNv^PO^PrCl
O Ù
F t N \^ P \ N H \^ C O E t  
OiPr 2
(120)
i, PCl^; ii, glycine ethyl ester
(Scheme 33).
55.
1-111 l_J IV, VF tN \/P O M e ^  ^ PhCHOCONH\^POJ^eH >
0




P h C H p C O N H ' ^ P ' ^
(121)
i, HgNNHg; ii, PhCH^OCOCl; iii, NaOH; iv, SOCl^, 
V ,  phenylalanine methyl ester; vi, LiOH.
(Scheme 34).
Bartlett^^^ also devised a novel strategy for the inhibition 
of carboxypeptidase A (CPA). The endophosphonodipeptide (121) 
may be regarded as a transition state surrogate for the tetrahedral 
intermediate in the proposed mechanism for CPA-catalysed peptide 
hydrolysis. Thus (121), an analogue for the transition state of 
z-Gly-L-Phe, having a phosphonamidate moiety in place of the scissile 
peptide group, was shown to be a competitive, reversible inhibitor 
of CPA.
56.
Merck^^^ have synthesised phosphonamide (122) and 
related compounds as potential angiotensin converting 
enzyme (ACE) inhibitors and antihypertensives.
, R







147Squibb have also examined phosphosponamides (123) for the 
same reason.
R- CG-NH-v^ ^ p - a -CQX^ or3
(123)
wherein A is — N — C H
57.
Compounds of general formula (122) and (123) were synthesised 
via the corresponding N-protected aminophosphonomonochloridate.
VIII The Enkephalins
In the early 1970's Lieoeskind and his associates were
able to demonstrate that electrical stimulation of specific
14 8brain sites in the rat produced profound analgesia
149which was naloxone reversible , and subject to tolerance
150development and to cross-tolerance to morphine . These 
results were explained by the electrically induced release of an 
endogenous substance or substances with morphine-like properties. 
Close correlation was also observed between brain areas most 
sensitive to stimulation-produced analgesia and regions 
containing a high density of opiate receptors.
Early in 1975 evidence emerged that these endogenous opioids
151were peptides rather than simple morphine-like molecules
Extracts from pig brain provided in 1975 by John Hughes showed
152these endogenous opiods to be two peptides , each with five 
amino acids and differing only in the carboxyl terminal amino 
acid. (Fig. 2). They christened them methionine (Met) and 
Leucine (Leu) enkephalin, the term enkephalin being coined from 
the Greek word meaning "in the head". The enkephalins appear




C O N H ^ ^ C O N H CONH COHCONH
Me
Met-enkeptialin
Fig.2 . Methionine and Leucine enkephalin
Evidence has shown that enkephalins function at the neuronal
154level as presynaptic neurotransmitters 
in nerve terminals and are released by depolarising stimuli
They are concentrated 
155
The opiate receptor sites that have Deen most widely 
studied are those of the Guinea Pig ilieum (GPI) and Mouse 
Vas deferens (MVD) tissue preparations. The receptors at these
59.
sites are called y and <S respectively. Initial studies on 
3H-enkephalin binding to opiate receptors revealed a different 
order of relative potencies for certain opiates than that
3
previously seen under H-opiates. In addition the enkephalins 
were far less sensitive to the effects of sodium ion on binding 
affinity. Lord and KostarVcVz, also found that Met- and Leu- 
enkephalin demonstrated an enhancement of (MVD) activity over 
(GPI ) activity . This led them to suggest that the enkephalins 
interact more specifically at the 6 -opiate receptors.
More recently a new opiate-receptor has been discovered 
called kappa (k ), These receptors can be found in high 
concentration in the Rat Vas deferens (RVD). The Table ? 
shows the different types of opiate receptor and summarises 















The heterogeneity or binding sites (y ,6 ,k .... ) would 
explain the wide range of pharmacological effects elicited by 
administration of non-discriminant drugs such as morphine.
With the concepts of receptor multiplicity detailed considerations 
of opiod structure reactivity relationships have been 
undertaken to prepare new molecules exhibiting the highest 
possible specificity for each kind of receptor and thereby 
reduce any unnecessary side effects.
A. Identification of functional Groups Required for Biological 
Activity in the Enkephalins 
Early structure-activity data for the enkephalins 
demonstrated that 1) the phenolic group of Tyr^ was important
for activity and 2) (desamino-Tyr^ ) Met-enkephalin was
159devoid of biological activity , It has also been shown that 
the appropriate spatial conformation is available for the phenolic
ring and quaternary nitrogen present in the phenanthracene nucleus
1 160 of opiate alkaloids and Tyr of the enkephalins . These
observations indicated that Tyr^ of the enkephalins provided
two sites for binding at the opiate receptor. The necessity of
Phe^ was also shown for enkephalin recognition^^^'^^^and several
investigators have related the aromatic side chain of Phe^ with
the 19-Phenethyl substituent (F ring) of the opiate compound
7-(l-phenyl-3-hydroxybutyl)-3-endoethenotetrahydrothebaine 
,163(P.E.T.) ' These observations have been confirmed
and novel analogues of enkephalins have been prepared to
identify the functional groups required for biological 
166activity . The effect of structural change at each amino acid
position has been studied using either Met-enkephalin, Leu-
61.
enkephalin or a more stable enkephalin analogue 167
H
Leu-enkephalin P. E.T.
A simplistic model of a receptor site is shown where one
aromatic subsite (T-site) preferentially binds the hydroxylated
rings (as in morphine and tyrosine in enkephalin). The
oanionic site is ^  4.5A from the centre of the ring to the 
piperidine nitrogen. The second aromatic site and the site 
that binds the non-hydrosylated flexible equatorial aromatic 
ring such as mepherdrine or the phenylalanine in enkephalin.
The steric hump interacts with substituents at C14 (morphine) 




B, Enkephalin Analogues Containing aminophosphonic and
aminosulphonic acid residues at the C-terminus
Bajusz replaced the residue at position five of the
enkephalins with an appropriate aminophosphonic or amino 
168sulphonic acid , The opiate agonist activities determined 
in MVD and GPI tissue preparations are summarised in table 3 .
Generally higher potencies were obtained in the MVD than 
the GPI. Thus the bulky, dibasic -PO^H^ group at the C- 
terminus seems to be preferred or tolerated more by the 
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Many peptide analogues containing phosphorus have been 
synthesised and biologically assessed. The molecules most 
studied have C-terminal phosphonic or phosphinic acids or 
contain phosphoramide or phosphonate moieties.
Peptide analogues containing phosphonamide bonds have 
received little attention. The synthesis of an analogue of 
an endogenous peptide with a phosphonamide link has never 
been reported.
The synthesis of an endophosphonoenkephalin will be 
discussed with the aim to producing:
1) a substrate that may bind to an enzyme forming a stable 
transition state surrogate





1. Modes of Peptide hydrolysis oy carboxypeptidase
All but one of the amide bonds in Leu and Met
169enkephalin may be hydrolysed enzymatically . The sites of 




The zinc peptidases constitute an important class of
proteolytic enzymes, from both the mechanistic and biological 
170standpoint . Carboxypeptidase A (CPA) is the leading
representative of this group. It is specific for the cleavage
of C-terminal amino-acids from oligopeptides, favouring those
with aromatic side chains. X-ray crystallography has defined
171the configuration of the enzyme active site , and has led to
widely accepted mechanisms of peptide hydrolysis by zinc 
172containing enzymes . The two probable mechanisms both of which 




























| - G l u C O -  4 . | A o h + HN 2
+ HOTyr-
69.
Bartlett’s interest in tetrahedral phosphorus
174derivatives as stable mimics of tetrahedral carbon intermediates
led to the preparation of a phosphonamide - analogue of a CPA
substrate, carbobenzoxyglycyl-L-phenylalanine. This analogue
N- [ [ [ (benzyloxycarbonyl )amino]methyl] hydroxyphosphinyi]!-L-
phenylalanine, dilithium s a l t ( 1 2 1 ) was designed to resemble the
tetrahedral adduct formed during peptide hydrolysis. This was




Bearing in mind the sites of enkephalinase attack, an 
enkephalin analogue containing a phosphonamide bond between 
gly-phe might well be expected to be an inhibitor of dipeptidyl 
carboxypeptidase "Enkephalinase A". This work describes our 
synthetic efforts towards the synthesis of an endophosphono 
enkephalin.
70.
2, Evaluation of coupling methods for the formation of 
phosphonamide peptide analogues
a ) Attempted coupling of aminophosphonic acids oy the 
mixed anhydride method.
The coupling of aminophosphonic acids using
dicyclohexylcarbodiimide (DCC) has been reported to be
142unsuccessful . The use of carboxylic-phosphonic anhydride 
systems for the formation of phosphonamide has not been described
Carboxylic-phosphinic anhydrides have not received much 
attention, however, some information concerning the cyclic 








In this case an important change in regiospecificity 
depending on the nature of the nucleophile was observed. 
Aminolysis followed path(a) whereas alcoholysis occurred by 
attack at phosphorus.
71.
We investigated the activation of N-oenzyloxycarhonyl 
phosphonophenylglycine using pivaloyl chloride. Although
1 7 crit was demonstrated that amines were better nucleophiles 
for carbon than for phosphorus in the carooxylic-phosphinic 
anhydride (124)^ jt was anticipated that in our case steric 
hindrance due to the t-butyl groups could reverse this 
discriminatory effect. In fact the only product isolated was 
(125) due to attack at carbon (Scheme 35). This compound was 
characterised by NMR and mass spectrometry.
As a test of the relative merits of pi va lie and diphenyl-
17 5phosphinic (DPP) mixed anhydrides compound (126) was prepared 








P h ^ ' ^ O C O N H - s .  -  V
Y ^ C O B u*
P h ^ ^ C O N H  +  BuCO NH\^CO M e
Ph th  ^
(125)
i, (CHg)gCOCl, -23°C, Et^N 2 eq; ii, Phenylglycine methyl ester,
( Scheme 35. )
73.
175Our studies concur with the reported observations 
and demonstrate that mixed carboxylic-phosphinic anhydrides 
are not suitable for the formation of phosphonamides 
(Scheme 35).
We also studied phosphonic-phosphonic and phosphonic- 
phosphinic anhydrides of type (128). These have also proved 
unsuccessful in phosphonamide formation.
R = OPh, Ph, GEt
(128)
When R=Ph, OPh, no coupled products were isolated after 
hydrolytic work up including acid and base extraction. When 
R was OEt compound (129) was isolated (Scheme 36), the structure 
of which was clear from NMR data. The NMR spectrum showed 
a singlet at 3.78 due to the caroomethoxy ester and signals at 
1.2 and 3.9 due to the phosphorus esters.
74.
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FtNŝ (j3-0_P0Et —iL_̂  
OMe 3 2
(130)








The formation of anhydride (130) was assumed in Step i 
when the precipitation of N-methyl morpholine hydrochloride 
was observed. Another explanation could be that the 
anhydride (130) had not formed and the phenylalanine methyl 
ester was reacting with unchanged diethyl chlorophosphate.
From these studies it was concluded that phosphonic-phosphinic 
or phosphonic-phosphonic mixed anhydride systems were also not 
suitable for phosphonamide formation.
b ) Coupling reactions of phosphonochloridates with
C-protected amino acids and peptides
The formation of phosphonochloridates directly from
phosphonate esters has been accomplished using phosphorus 
141pentachloride . However, as the reaction requires elevated 
temperatures, such as refluxing toluene, its use is relatively 
limited to molecules containing functional groups that can 
withstand the reaction conditions. The reaction has been
employed successfully for N-phthaloyl protected aminoalkyl
 ̂ 141,142phosphonates
Our attempts to prepare phosphonochloridates directly 
from aminoalkylphosphonates with N-urethane and N-alkyl protection 
were unsuccessful.
143Bartlett reacted thionyl chloride with N-benzyloxycaroonyl
76.
aminophosphonic acid (131) giving the N-protected aminophosphono- 
chloridate (132) which coupled successfully with phenylalanine 
methyl ester to yield the dipeptide analogue (133), Scheme 37.
n
Ph/^O C O N H  ^ >
OMe
(131)
1/Cl Ph/NDCONH \ 8. 







i. SOClg; ii Phenylalanine methyl ester, Et^N 1 eq,
( Scheme 37.)
77.
However, Balfeett synthesised (131) from the corresponding 
phthalimidomethyl dimethylphosphonate. This methodology was 
apparently chosen instead of utilising phosphorus pentachloride 
directly as removal of the N-phthaloyl functionality at a later 
stage may have proved impracticaole. (See Section 4).
N-Phthaloyl protected endophosphonopeptides were prepared 
oy Japanese workers and the N-phthaloyl group successfully removed 
using hydrazine Although the yields of these reactions
were not very high the shorter route to phosphonamides compensated,
From the known methods availaole for phosphonamide formation 
from phosphonochloridate we decided to attempt to form the 
phosphonochloridates directly from N-phthaloyl protected 
aminoalkylphosphonates. This would enable us to employ the most 
economic route in terms of the number of steps into phosphonamide 
systems, and to investigate conditions for removal of phthalimide 
or related protecting groups.
We demonstrated the formation of the phosphonochloridate
(134) by Observing the downfield shift and change in coupling 
constant Jp ^ of the methylene protons in (134) relative to the 
dimethyl ester. Upon deuteration of phosphonochloridate (134) 
the resonances due to the methylene protons occurred at higher 
field as compared to (134). After hydrolysis of (134) we 
isolated the novel monophosphonic acid (135) the structure of 
which was confirmed by NMR signals at 6 7.85 (aromatic) 3.7-3.95 
(CH P, J llHz) and 3.5-3.75 (P-OCH , J llHz). The IR spectrum
showed stretches at 3400-2700 (P-OH), 1790, 1740 (0=0)
— 1and 1050 (P=0)cm
78.
Having found suitable conditions for the formation of the 
phosphonochloridate (134) we synthesised the phosphonamide 
dipeptide analogue (136) as shown in Scheme 38.
i f l / C l
F tN \ /P Q M e  --------- >
 ̂  ̂ OMe
(137) /  \ (134)
11 111
^ P h  OH
(136) (135)
i, PCl^; ii, Phenylalanine methyl ester, Et^N 1 eq. iii, H^O
(Scheme 38).
79.
The NMR of (136) indicated resonances at 6 3.61
(P-OCH^, Jp^ llHz) and 3.68 (CO^CH^). The IR spectrum showed Stretches
— 1at 1780, 1720 (0=0) and 1040 (P=0)cm . MS showed m/z 417 (m+1).
The structure of (136) was confirmed by OMR and elemental 
analysis.
We extended the methodology in order to synthesise the
phosphonic acid (138) from phalimidomethyl dimethylphosphonate
(139) (Scheme 39). Treatment of (137) with excess bromotrimethyl-
silane followed by hydrolysis of the bis-trimethylsilyl ester
produced (138). The structure of (138) was demonstrated by
NMR resonances at 67.8 (aromatic) and 3.7-3.95 (OH^P, Jp^ llHz).
IR spectroscopy indicated 3500-2700 (P-OH), 1710 (0=0) and 1000 
-1(P=0) cm , Reaction of (138) with excess thionyl chloride 
yielded the phosphonochloridate (139). The formation of this 
key unstable intermediate was indicated by the ^H NMR spectrum 
in which signals attributed to the methylene protons appeared at 
lower field 6 5.05-4.85 Jp^ 6Hz relative to the diacid 3.95-3.7 
Jp^ llHz and diester 4.18-4.01 Jp^ llHz. Hydrolysis of (139) 
resulted in the formation of (138) confirming its intermediacy in 
our synthesis of (140). The phosphonochloridate (139) was then 
coupled without isolation with glycine methyl ester and the 
product quenched with methanol to yield (140) (Scheme 39).
The structure of (140) was indicated by its ^H NMR spectrum, 
signals at 6 7.8 (aromatic), 3.82 (P-OCH^, Jp^ llHz) and 
3.76 (COgMe) were observed. IR spectroscopy showed signals at 
1780, 1750, 1710 (0=0), 1220 (OMe) and 1140 (P=0) cm” .̂
80.
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■> — . X O M e
01iMe
(140)
i, TMSBr 2.5 eq. H^O/acetone»1:9; ii, SOCl^»excess.
iii, glycine methyl ester, Et^N 1 eq., iv. MeOH, Et^N,1 eq,
(Scheme 39. )
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The formation of phosphonamides via phosphonodichloridates 
such as (139) has not previously been reported. However, the 
yield of (140) in Scheme 39 was poor (17%).
We decided to further extend the aoove methodology to the 
synthesis of oligopeptide analogues (142), (143), (144). Our aim 
was to synthesise an enkephalin analogue containing a phosphonamide 
moiety.
We prepared tri and tetraphosphonopeptides (142) and (143) 
respectively from the dipeptide analogue (141), Schemes 40, 41.
Key steps in these syntheses involved the removal of the 
N-phthaloyl functionality with hydrazine and coupling the 
resulting free amine with an activated ester of an N-protected 
amino acid or peptide. The structures of (142) and (143) were 




















BzlIi, NH^NH^; ii, Z Tyr gly-OH, DCC
(Scheme 41).
(143)
A problem encountered in these syntheses was that the 
dicyclohexylurea (DCU) formed in the coupling reaction was 
difficult to remove from the product since it streaked into the 
product upon chromatography. As an alternative we chose diphenyl- 
phosphinyl chloride as the reagent for active ester formation.
The product from this reagent after coupling is water soluble and 
thus readily removed.
83.
The free amine resulting from the hydrazinolysis of (141) 
was not isolated. However, its formation was implied by the 
products formed, e.g. (142) and (143).
Having demonstrated our method of phosphonamide formation and 
extension of the peptide backbone to oe successful we went on to 
synthesise an endophosphonoenkephalin by a convergent route 
represented in Scheme 42.
©
gly + phe-leu 
©
Tyr-gly + gly-phe-leu ©
Tyr-gly-gly-phe-leu
(Scheme 42).
The tripeptide (144) was synthesised as shown in Scheme 43
and its structure demonstrated oy H-NMR 67.8-7.3 (aromatic),
3.8 (P-OMe, llHz), 3.6 (CO^CH^), 0.9 ((CHg)^). The IR spectrum showed
stretches at 1780, 1750, 1710, 1650 (0=0), 1250 (P-OCH^), 1050 
— 1(P=0) cm . The structure of (144) was confirmed by MS, 
m/z 530 (m+1), CMR and elemental analysis.
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C O ^ e
11
(145)
i, NH NH 2 2; ii, zJ-
Bzl
yrglyOH + DPPCL + Et^N
(Scheme 44.)
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We then extended the ahove method to prepare the pentapeptide 
analogue (145) (Scheme 44). The enkephalin analogue (145) was 
an important synthetic target. Its structure was elucidated 
from ^H-NMR which showed resonances at &3.5 (P-OCH^, llHz),
3.64 (CO^CH^) and 0.88 ((CHg)^). MS showed m/z 844 (Mfl) and 
amino-acid analysis indicated (gly 1.01, leu 0.92, tyr 0.97, 
phe 0.91). The yield of (145) from (144) was poor, prooahly 
due to hydrazine initiating cleavage of the -P-N system in (144). 
This was suspected oecause phenylalanyl-leucine methyl ester was 
detected by t.l.c. in the reaction mixture. For a practical 
synthesis of (145) alternative methods of protection and 
deprotection of (144) need to be established. Furthermore a 
detailed study of the stability of the -P-N- system in phosphono- 
peptides should prove useful in order to optimise reaction 
conditions.
The deprotection of (145) has so far been unsuccessful.
The methods of deprotection attempted have included; 1) The 
use of ammonium formate with 10% Pd/C; 2) Treatment with boron 
tribromide followed by hydrolysis; 3) Reaction with bromotrimethyl- 
silane followed by hydrolysis; 4) Reaction with sodium hydroxide.
The attempted deprotection of (145) using bromotrimethylsilane 
looked the most promising as ^H-NMR indicated the absence of 
phosphonate ester and benzyoxycaroonyl resonances. However, ^H-NMR 
also showed that deprotection of the 0-benzyl ether was not complete 
and a signal assigned to the caroomethoxy ester was also present. 
Reverse phase chromatography indicated that one major product was
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present. The product reacted with ninhydrin indicating the 
presence of a free amino function. The IR spectrum 1740-1650 (C=0) and 
1050 (P=0) cm . However, no satisfactory mass spectral data was 
Obtained in order to support a structure for this product.
No completely deprotected endophosphonopeptide of this 
type has ever been isolated. Out attempts at deprotecting
(145) and isolation of such a product have proved unsuccessful, 
The fact that we were unable to isolate a deprotected product 
leads us to propose that such products might be unstable.
c ) Summary
In the above studies we have investigated the coupling 
methods for formation of phosphonamides. We have also 
employed our methodology in the synthesis of peptide analogues 
with two to four units. The synthesis of the target 
endophosphonoenkephalin has also been accomplished, albeit 
in fully protected form as conventional deprotection failed 
to give the free pentapeptide.
Further studies on the stability of the phosphonamide 
system in these peptide analogues will now be discussed.
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3, Kinetic Studies on the hydrolysis of a phosphonamide 
dipeptide analogue
(a) H.P.L.C. Studies on the dipeptide analogue (136)
It has been suggested that phosphonamides are both acid 
178and base labile . However, no studies on the stability of 
the P-N link of phosphonamide systems in peptides have been 
reported. As peptides containing phosphonamide oonds may 
be chemotherapeutically important it is essential that the 
stability of the phosphonamide system is known over a range 
of pH values 1 - 1 2 .
We prepared the dipeptide analogue (136) from 
phthalimidomethyl dimethylphosphonate as shown in Scheme 38.
The product was shown to be spectroscopically pure and 
homogeneous by h.p.l.c. and t.l.c. By developing h.p.l.c. 
systems for the detection of (136) and its hydrolysis products 
the mechanism and rate of hydrolysis of (136) were investigated over 
a range of pH.
Several mechanisms of hydrolysis involving initial attack 
at the P-N system were thought to be possible, these included:





(2) Nucleophilic attack at phosphorus and displacement of 
methoxide, followed by further reaction at the phosphonic system 







(3) Metaphosphonate formation via an E^CB pathway with 






Mechanisms involving hydrolysis of the caroomethoxy ester 
and phthalimide functions were also considered possible. 
These included:
(1) Hydrolysis of the carbomethoxy ester and formation of a 
cyclic anhydride by nucleophilic displacement of methoxide,
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followed by hydrolysis of the cyclic anhydride intermediate
FtN NH
(o M e 1^,
(2) Hydrolysis of the phthaloyl protecting group with 
subsequent attack at phosphorus and displacement of either 
methoxide or phenylalanine methyl ester forming a cyclic 




R = OMe or
phenylalanyl
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Bartlett^^^ has recently studied the rearrangement and 
solvolysis of N-(Amino(methyl)phosphinyl)-L-phenylalanine 
derivatives. In his proposed mechanistic pathways 
Bartlett^^^ discussed the involvement of transient intermediates 
(150) and (151) Scheme 44. Such intermediates arose either 
by cyclisation of a phosphorus-oound nucleophile on the acyl 
carbon (path a ) or by cyclisation of a caroon-bound nucleophile 
on the phosphorus centre (path d ). In hydroxylic solvents,
the intermediates (150) and (151) underwent rapid cleavage, 
exclusively at phosphorus, to give nucleophilic transfer and 
solvolysis (path a) or catalysed solvolysis, path (b).
( f  ^N u-
Nu = NH; X = OMe
(150) Nu = NH
(151) Nu = 0
\/
ROH Me
Nu = NH; X = OMe 
or Nu = 0; X = NH
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In our study the identification of the products of hydrolysis 
and determination of the order of hydrolysis provided an 
insight to the mechanisms by which hydrolysis was occurring.
We synthesised the mono- and diphosphonic acids (135) 
and (138) as shown in Scheme 45. The structures of (135) 
and (138) were confirmed by NMR, IR, MS, and elemental analysis,





1 1 1 ,  I V
»  FtN
(138)
i, PCl^, ii, HgO; iii, TMSBr; iv, acetone-water 9:1
Scheme 45.
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Other possible products arising from the hydrolysis of
(136) were phenylalanine methyl ester, phenylalanine and 
phthalic acid. The h.p.l.c. systems that were developed 
for the detection of the products of hydrolysis using reverse 
phase chromatography are shown in Table 3. All separations 
were carried out using Spherisoro 5 y ODS 25mm x 4 m.m. i.d. 
as the stationary phase.
Having developed chromatographic separations for the 
hydrolysis products, the hydrolysis of (136) was examined at 
various pH values (1 - 12). In a typical procedure 2Qmg of (136) 
was dissolved in 10 ml of methanol and 100 y 1 of this solution 
added to 10 ml of buffer solution. A 20y 1 injection from each 
buffer solution was taken at different times and the disappearance 
of the peak due to (136) noted. Detection of the products 
of hydrolysis was carried out using lOOy 1 injections from the 
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Table 5 shows the pH range investigated during our 
stability studies.
Table 5.
pH Solutions used to ootain correct pH
1 0.1 M HCl
1.5 HCl 0.2 M/KCl 0.2 M 1:1
2.6 0.1 M NaClO /^^lOO HCIO, ^ 4 4
3.1 citrate buffer
4 0.1 M NaOAc/0.1 M HOAc °
7 NaHgPO^ 0.1 M/Na^HPO^ 1:1
8.5 citric acid/NaOH ^
9.5 citric acid/NaOH ^
10 citric acid/NaOH ^
M/a pH adjusted by addition of 100 HCIO^ to 0.1 M HCIO^
b pH adjusted by addition of 0.1 M HOAc to 0.1 M NaOAc
c pH adjusted by addition of 2M NaOH to 2M citric acid
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Our h.p.l.c, studies showed conclusively that (136) was stable 
between pH 1-7 at room temperature, i.e. no decrease in 
concentration of (136) was observed in the solutions between 
pH 1-7 after several hours. Hydrolysis of (136) occurred at 
60°C at pH 1 with pseudo-first order kinetics. A logarithmic 
plot of concentration of (136) against time gave a straight 
line. Both phenylalanine methyl ester and phthalimidomethyl-
0-methyl phosphonic acid (135) were detected in the hydrolysis 
mixture.
Under basic conditions hydrolysis of (136) was more 
facile. Below pH 10 pseudo-first order kinetics were observed 
for the hydrolysis of (136). A logarithmic plot of 
concentration of (136) against time gave a straight line.
Again both phenylalanine methyl ester and phthalimidomethyl-0- 
methyl phosphonic acid (135) were detected in the hydrolysis 
mixtures.
The chromatographic systems used for product detection 
were carefully chosen in order that other possible hydrolysis 
products could be detected. However, no other products were 
detected.
The rate constants, half life of hydrolysis of (136) 
and correlation coefficients for the pseudo-first order 
hydrolysis of (136) are shown in Table 6 .
97.
Table 6 .
pH “1rate constant (s ) Half life (s) correlation
coefficient
1 60°C 1.9 X 10"4 3.56 X 10^ 0.999
9.5 4.48 X 10“^ 1.51 X 10^ 0.996
10.0 —44.5 X 10 1.51 X 10^ 0.995
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The computer "print-outs” for the plots of log concentration 
against time for the above pH ranges are shown below.
HQ □ BS A REAC T CAL C A V r e a c t RES ID
1 1.10 ij 9408.00 0 2.472 9581 .914 1.220 --1.2891E+022 10.2ÛÛ 8582.00 0 10.822 8578. 825 10.854 8.1752E+Û0
3: 12.650 7867.00 0 18.050 77 05. 892 19.684 1.6161E+Ù2
4 3:0.100 7086.0 00 25.945 6881 . 172 28.521 2.5488E+025 45.5 3:0 54 81.00 0 42.676 571 8. 096 89.824 --2. 821 ÜE+02
6 61.83:0 4591.000 51.167 4723. 417 49.829 --1 . 8242E+02
7 36.88 0 8614.00 0 61 . 044 851 8. 471 62.060 1.ÛÛ58E+Ù28 104.88 0 2849.00 0 68.777 2880. 718 68.962 1.8287E+01
K = 1.1155Ê-02 ' M-1 LOG = -1 . 9525 h a l f  LIFE = 6.S:187E+i:H MINK = 1.8522E-04 S-1 LOG (K' = - 8. 7 807 HALF LIFE = 8.7’282F-nY8 PCT;p=y+B+EXP(-K+T A=F (INFINITY) = -289.6 22 F' 0 =  9658 . 556
FRACTION CHANG E IN K IH CYCLE 1 9 =  1.82 08E-09
□VERRELAXATIDN FACTOR IN CYCLE 19 = 2. 0 0
ST DEV FOP K = 8-. 1291E-04 5 .494 COFF COEFF = 0.99956
ST DEV PD-' A = 1.4628E + 02 1.479 % 1-R+R = 8.6577E-0'
NO T(MIN) conc LN(X) LN(X)EST-LN(X)
1 0.93 84935.000 0.0000 0.0128
2 7.43 80533.000 0.0532 -0.0226
3 15.08 79905.000 0.0610 -0.0094
4 31.10 79125.000 0.0709 0.0249
5 166.06 52644.000 0.4783 -0.0114
6 250.48 42453.000 0.6935 0.0056
* 70.83 61090.000 0.3295 -0.1245
INFINITY 0.000
K = 4.5840E-05(S-1) L06(K) = -4.339 HALF LIFE = 1.5121E+04 SEC
K = 2.7504E-03(M-1) LOG(K) = -2.561 HALF LIFE = 2.5202E+02 MIN
CORR COEFF = 0.996281 ST ERROR = 1.4003E-06 S-1 ( 3.055 % )
NO T(HIN) CONC LN(X) LN(X)EST-LN(X)
* 0.67 70020.000 0.0000 0.2667
2 7.42 49011.000 0.3567 0.0880
3 14.22 38919.000 0.5873 0.0366
4 20.98 29235.000 0.8734 -0.0713
5 28.96 25822.000 0.9976 0.0149
6 35.96 21107.000 1.1992 -0.0022
7 43.23 15920.000 1.4812 -0.0926
8 79.55 6859.000 2.3232 0.0227
9 102.35 3918.000 2.8832 0.0637
10 72.75 7555.000 2.2266 -0.0599
INFINITY 0.000
K = 4.3931E-04(S-1) LOG(K) = -3.357 HALF LIFE = 1.5778E+03 SEC
K = 2.6358E-02(M-1) LOG(K) = -1.579 HALF LIFE = 2.6297E+01 MIN
CORR COEFF = 0.994776 ST ERROR = 1.2032E-05 S-1 ( 2.739 % )
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Above pH 10 hydrolysis of (136) occurred rapidly and 
phthalic acid was detected in the hydrolysis mixtures.
Thus the phthalimido moiety of (136) was being hydrolysed 
at elevated pH. From our studies we knew that (136)
3
hydrolysed at pH 10 with a half-life of 1.51 x 10 sec.
(m^ 25 mins). Hence higher pH must be minimised or avoided 
completely in any manipulations with phosphonamides such as 
(136).
The product analysis of the hydrosylates between pH 1 - 10 
suggest that the mechanism of hydrolysis is attack at 
phosphorus with displacement of phenylalanine methyl ester.
(b ) Summary
Our studies showed that (136) hydrolyses via pseudo-first 
order kinetics between pH 1 - 10. The mechanism of hydrolysis 
was implied from the hydrolysis products observed.
Having investigated the stability of a phosphonamide 
system over a range of pH we now have a far better guide of 
the pH limits under which experiments may be conducted with 
peptide analogues containing a phosphonamide system .
As our present method of removal of phthalimide involves 
hydrazine, which is both nucleophilic and basic, it seems 
reasonable that the conditions of the reaction result in some 
cleavage of the phosphonamide system. Our studies therefore led 
us to investigate other possible N-protection that would be 
labile under less basic conditions.
100.
4. Studies on N-phthaloyl deprotection and the synthesis of 
novel N-protected dimethyl phosphonates
a) Removal of phthalimide py hydrazinolysis
The synthesis of phosphonamides utilised in our study involved 
coupling of N-phthaloyl phosphonochloridates with amino acid or 
peptide esters. Although phthalimide is an excellent protecting 
group its removal has proved trouhlesome in our hands. Until 
recently the most common methods of phthalimide removal involved 
hydrazinolysis, i.e. strongly basic conditions, Scheme 46. We 
have successfully used hydrazine to remove phthalimide from 
phosphonopeptides, however, the yield was low due to P-N bond 
cleavage of the phosphonamide. Also the by-product of hydrazinolysis 







The use of methylhydrazine was reported an advantage being that
the N-methyl phthalhydrazide by-product was more easily separable 
from the product. However, in our case yields were not improved 
using methylhydrazine as the basicity was still thought high














A milder, less basic system using sodium sulphide has
been described In this case the acidic intermediate
178(153) was activated using mixed anhydride methods , yielding
an iso-imide (154). Hydrazinolysis of the iso-imide formed
178was reported to be more facile than phthalimide, Scheme 47. 
When applied to our phosphonopeptides no improvement in yield 
after deprotection of phthalimide was observed. From our 
Observations above, and stability studies on (136) over a 
range of pH it was apparent that if yields of deprotected 
product were to be improved, basic conditions would have to 
be minimised or avoided altogether.
b ) Removal of phthalimide using sodium borohydride
179Recently Ganem described a novel method of phthalimide 
cleavage. The phthalimide group was treated with sodium 
borohydride in propan-2 -ol affording an a-hydroxymethyl 
benzamide analogue (155), which upon treatment with acetic 
acid produced the deprotected product (156) and an easily 




i, NaBH^, propan-2-ol; ii, AcOH
( Scheme 4 8.)
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When applied to our systems, the use of excess sodium 
borohydride was unsuccessful, with P-N bond cleavage observed, 
and phenylalanyl-leucine methyl ester detected by t.l.c.
Treatment of (137) and (144) with 1 equivalent of sodium 
borohydride afforded the a-amidoalcohols (157) and (158)
(Scheme 49). Compound (157) exhibited characteristic stretching 
frequencies in the IR spectrum at, 3350(0H), 1700(C=0), 1050(P=0) cm  ̂
The mass spectrum showed a molecular ion m/z 271 and the^H-NMR
and CMR showed the presence of -CH-OH with shifts of 6 6.01 and
1 136 167 for H and C respectively.
Similarly compound (158) showed in the IR spectrum, 3350 (OH),
■"1 11740 (COgMe), 1680 (CONH) and 1050 (P=0) cm . H-NMR indicated 
resonances at 66.01 and 5.90 (CHOH), 3.62 (CO^Me), 0.85 ((CHg)^). 
These resonances were also observed in the CMR spectrum at &82.5 
(CHOH), 52.17 (OCHg), 22.8 and 21.7 ((CH^Xg). FAB MS showed 
m/z 532 (M+1 ) and 530 (M-1).
The &-amidoalcohols (157) and (158) were stable when 
heated with acetic acid. As excess borohydride is required 
to form the a-hydroxymethyl benzamide analogues such as (155) 
and our systems are not stable to excess borohydride this 
















We have employed hydrazine in the deprotection of 
N-phthaloyl phosphonopeptides. The basic conditions 
resulting from hydrazinolysis are such that low yields of 
desired products are observed due to phosphonamide P-N bond 
cleavage. It would therefore be advantageous to investigate 
other forms of N-protection for our systems in order 
to improve yields of deprotection and hence coupling.
5. Synthesis of some novel N-protected aroinoalkylphosphonate 
esters.
Introduction
This section is concerned with our approaches to the 
synthesis of some new N-protected aminoalkylphosphonate esters 
with the aim of developing a protecting group that would:
1 ) survive the conditions of phosphonamide formation^.and 
2 ) could be easily removed after coupling was effected.
a ) The N,N-dibenzyl protecting group
Recently the N,N-dibenzyl phosphonate (159) was reported^^^ 
and synthesised as shown in Scheme 50.
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PItv %NH +  HCHO + HROM^-
(159)
(Scheme 50).
The removal of N,N-dihenzyl protection has oeen effected 
using palladium black and 4.4% formic acid in methanol as a 
hydrogen donor. We investigated this approach for the removal 
of the N,N-dibenzyl groups in (159). In our studies we observed 
that reaction of (159) with palladium black and 4.4% formic acid 
in methanol not only cleaved the N,N-dibenzyl protection but also 
removed one of the phosphonate methyl esters, giving (160) as 
the product. The ^H-NMR of (160) showed only two doublets 
integrating in a ratio 3:2 6 3.1 (CH^P, 12Hz), 3.6 (P-OCH^,
lOHz). The CMR of (160) also indicated two doublets 6 59.33
and 52.95 (P-OCH^, J^p 6.1Hz), 38.3 and 31.9 (CH^P, J^p 144Hz). 




When (159) was treated with phosphorus pentachloride 
followed by attempted phosphonamide. formation with an amino 
acid or peptide ester unreacted starting material was recovered. 
Apparently (159) was not reacting with phosphorus pentachloride 
to give the required phosphonochloridate. This lack of the
required reactivj,ty. may possibly be due to the lone pair on the 
tertiary amine complexing with the phosphorus pentachloride, 
thereby preventing the required reaction from occurring.
b ) The N,N-diallyl protecting group
182The N,N-diallyl protecting group has also been employed
and has been found to oe easily removed using tris(triphenyl- 
phosphine)rhodium(I) chloride (Wilkinson's catalyst), followed 
by acid treatment
We synthesised the novel N,N-diallyl phosphonate (161) in 
a similar manner to the N,N-dibenzyl analogue (159) Scheme 51.
^H-NMR showed resonances at 5 5.65-6.1 and 5.1-5.35 (CH2=CH-),
3.75 (P-OCHg, Jp^ llHz). The IR spectrum indicated stretches at 1450(C=C)
-11250 (P-OCHg), 1050 (P=0) cm . Mass spectrometry showed a molecular 
ion at m/z 219 (M+). The structure of (161) was demonstrated by 







Wilkinson's catalyst is known to isomerise N-allyl 
groups to the corresponding enamines. Acidic treatment of 
which results in the formation of free a m i n e s ^ I n  our 
case, after treatment of (161) with Wilkinson's catalyst, 
followed by acid treatment, it appeared from NMR evidence 
that only one of the N-allyl groups had been cleaved. The 
integration over the N-allyl region relative to the phosphorus 
ester region indicated only one N-allyl group was present.
Attempted reaction of (161) with phosphorus pentachloride 
and subsequent phosphonamide formation with peptide esters was 
unsuccessful, only unchanged N,N-diallyl phosphonate (161) being 
recovered. Again the possibility of the lone pair of the 
tertiary amine complexing with the phosphorus pentachloride 
cannot be excluded, although the exact reason for the failure 
of this reaction sequence is not clear.
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c ) Mono- and dithiophthalimide protecting groups
Mono- and dithiophthalimide have been prepared oy 
184
Lawesson et al . The use of mono- and dithiophthalimide 
as protecting groups has not oeen reported.
We synthesised the novel dimethyl phosphonates (162)
and (163) as shown in Schemes 52 and 53 respectively.
Compound (162) showed H NMR resonances at 64.35-4.6 (CH^P,
12Hz), 3.55-3.75 (P-OCH^, Jp^ llHz) and CMR resonances at
6195.5 (C=S), 168.6 (C=0), 53.0 and 53.2 (P-OCH^, 4.87Hz),— o CP
39.3 and 32.4 (Çg^P, J^p 157 Hz). The IR spectrum of (162) showed
" 1characteristic stretches 1680 (C=0), 1350 (C=S), 1050 (P=0) cm 
High resolution mass spectrometry on (162) confirmed its elemental 
composition.
The structure of compound (163) was demonstrated from its 
^H NMR spectrum which indicated signals at 6 4.9-5.04 (CH^P, Jp^ 
12Hz), 3.7-3.85 (P-OCH^, Jp^ llHz), and CMR spectrum which showed 
resonances at 195.9 (C=S), 53.1 and 52.9 (P-OCH^, J^p 6.94 Hz), 
42.6 and 35.7 (CH^P), J^p 146.5 Hz). In the IR spectrum of (163) 
stretches were ooserved at 1350 (C=S), 1150 (P-OCH^), 1050 (P=0)cm 
High resolution mass spectrometry on (163) confirmed its elemental 
composition. All other compounds synthesised from either mono- 
or dithiophthalimide were novel and their structures confirmed oy 
their NMR, IR, MS, UV spectra and either high resolution mass 


















i, Lawesson's reagent ; ii, HCHO (aq.); iii, PBr^ ; iv, P(OMe)g
(Scheme 5 3).
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An interesting feature of compounds containing mono-
or dithiophthalimide groups was their colour. Compounds
with dithiophthalimide protection were dark red to hlack
crystalline materials and compounds with monothiophthalimide
protection were light red crystalline solids. Both classes
of compounds were shown to have characteristic UV spectra.
For example compound (162) showed X (EtOH) 327nm (e 7,143)max
and compound (163) indicated X (EtOH) 355nm (£ 19,095).max
However, attempted reaction of (162) and (163) with 
phosphorus pentachloride followed oy phosphonamide formation 
with peptide esters was unsuccessful. Only starting materials 
were recovered. The reason for this was unclear.
We have, however, demonstrated that mono- and 
dithiophthalimide protected amino acids can oe synthesised 
oy thionating N-caroethoxy phthalimide followed oy treatment 












i , Lawessons reagent; ii, phenylalanine methyl ester 
hydrochloride, Et^N; iii. Phenylalanine, NagCO^.
(Scheme 54).
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All compounds in Scheme 54 were characterised oy NMR, IR,
UV, MS or high resolution mass spectrometry.
d ) Summary
Methods of N-protection have been examined and some new 
N-protected phosphonate esters were synthesised. The
N-protected phosphonate esters synthesised did not form the 
required phosphonochloridates using our methodology. The 
applications of mono- and dithiophthalimide N-protection 
whilst not successful for our synthetic problem could still 
find a more general application in amine functional group 
protection and may eventually provide a viable alternative 
to some of the more conventional systems.
6 . The synthesis of some novel phosphonic acids.
The aminophosphonic analogue of leucine, l-amino-3-methyl
butyl phosphonic acid was prepared oy adapting a route first





































i, NaBH^; ii, TMSBr, 0/Acetone 1:9
(Scheme 56),
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As many simple phosphonic acids such as phosphonomycin 
are of biological interest, it was postulated that phosphonic 
acids derived from the intermediates shown in Scheme 55 might 
also exhibit useful biological activity.
The facile dealkylation of phosphonic acid dialkyl esters 
using bromotrimethylsilane (TMSBr) has been demonstrated by 
McKenna and co-workers^^^.
We prepared phosphonic acids (173) to (175) from the 
corresponding dimethyl phosphonates (169) to (172) by treatment 
with excess bromotrimethylsilane (TMSBr) followed by hydrolysis 
of the trimethylsilyl esters (Scheme 56). Compound (173) 
showed H NMR resonances at 63,78 (CH^CO), 2,2 (CH), 0.94 
((CHg)2 ). The IR spectrum showed characteristic stretches at 
3300-2700 (P-OH), 1710 (0=0), 1030 (P=0) cm"^. The MS of (173) 
showed m/z 166 (M^). Compounds (174) and (175) were characterised 
as for (173) above.
We also prepared the dipeptide analogue (176) via the 
activation of N-benzyloxycarbonyl phenylalanine using diphenyl 
phosphinyl chloride (DPPCl) and coupling this mixed anhydride 
with l-amino-3-methylbutylphosphonic acid dimethyl ester (172).
The structure of the coupled product was proven by NMR, IR and 
MS spectra. The N-benzyloxycarbonyl and phosphonate dimethyl 
ester groups were removed using hydrogen bromide in glacial acetic 
acid to yield (177). Compound (177) showed characteristic 
resonances in the NMR at 6 7.31 (aromatic), 3.2 (CH^Ph), 0,8 
((CHg)2 ). The CMR of (177) indicated signals at 6 169.9 (C=0),
118.
134-127 (aromatic), 52.98 and 51.42 (CHP, 110 Hz),
20.64 ((CHg)^). FAB MS on (197) showed m/z 315 (ro+1) 
and 313 (m-1).
PhCHOCONH POMeONH HN O N H OH
(176) (177)
The phosphonic acids (173) to (177) were submitted for oroad
spectrum antibacterial screening. No significant biological
activity was observed. Compound (176) may be of interest as a
possible key intermediate in the synthesis of exophosphono-
enkephalins. These have been demonstrated to show interesting
168properties at opoid receptors.
b) Summary
Some novel phosphosphonic acids have been synthesised and 
their antibiotic activities assessed. Compounds have been 




Melting points were determined using an Electrothermal 
Mk. II apparatus and are uncorrected. I.r. spectra were 
recorded with Perkin-Elmer 197 and 1310 grating spectrophoto­
meters. n.m.r. spectra were recorded at 60 MHz with
Perkin-Elmer R24B and Varian EM 360 spectrometers and at 
lOOMHz with a JEOL PS 100 spectrometer. 400MHz n.m.r. spectra
were recorded using the facility at the University of Warwick.
31P n.m.r. spectra were recorded at 40.5MHz with a JEOL PS 100 
13spectrometer and C n.m.r. spectra were recorded at 22.5MHz 
with a JEOL FX 90 Q spectrometer. U.V. spectra were obtained 
using Perkin-Elmer 402 and Lambda 3 spectrometers. Mass spectra 
were recorded on VG 7070E with VG 2000 data system, high resolution 
mass spectra were recorded on this system and by the Physical 
and Chemical Measurements Unit (Harwell).
Reactions were monitored by t.l.c. on Merck DC-Alufolien 
Kieselgel 60 using an appropriate eluent. Column
chromatography was carried out using pressurised short-path 
columns with Kieselgel 60 F^^^ Separation of small quantities 
was achieved by means of preparative t.l.c. on Merck 
PSC-Fertigplatten coated with Kieselgel 60 Fg^^.
Since reactions often produced complex mixtures it was 
found advantageous to use complementary methods of product 
detection.
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(a) Ultraviolet irradiation of t.l.c. plates impregnated with 
a fluorescent indicator.
(b) Iodine vapour was used as a general but indiscriminating 
reagent.
(c) A 5% ethanolic solution of anisaldehyde with a trace of acetic 
acid and concentrated sulphuric acid and heating was often used.
(d) A 5% Ammonium Molybdate in IM sulphuric acid was found to be 
extremely sensitive but indiscriminating.
(e) A ninhydrin solution containing 0.3g of ninhydrin in 100 ml 
of butan-l-ol and 3 ml of glacial acetic acid.
Amino-acid analysis was carried out using a Perkin-Elmer 
6AH amino-acid analyser.
Solvents
Petroleum ether refers to the fraction of b.p. 40 - 60°C 
and ether refers to diethyl ether. Other solvents were reagent 
grade unless otherwise stated. Solvents used for H.P.L.C. 
were ANALAR Grade. Solvents used for chromatography were 
redistilled and reaction solvents were generally dried by an 
appropriate procedure.
H.P.L.C. Studies
H.P.L.C. Studies were carried out using Spherisorb 5 ODS 25cm 
X  4mm i.d. as the stationary phase. A dual piston LDC Consta 
Metric pump and LDC Consta Metric spectromonitor detector were used. 
Traces were recorded using a Phillips PM 3252 dual pen recorder 
and peak areas measured using a Hewlett Packard 3390A integrator.
121.
Preparation of aminobenzyl phosphonic acid
Freshly distilled benzaldehyde (7.62 ml, 0.075 mol) was 
added at room temperature over 20 mins. to a stirred mixture 
of benzyl carbamate (7.56 g, 0.05 mol), phosphorus trichloride 
(A.35, 0.05 mol) and glacial acetic acid (10 ml). The mixture 
was heated at reflux for 40 min., treated with 4N hydrochloric 
acid (50 ml) and refluxed for a further 30 min. After 
cooling, the organic layer was removed and the aqueous layer 
purified by boiling with activated charcoal (2 g). The 
solution was filtered and evaporated to dryness in vacuo.
The residue was then dissolved in methanol (35 ml) and 
treated with 1,2-epoxypropane until pH 6-7 was reached.
The precipitated product was washed with acetone and 
recrystallised from methanol/water (1:2). This yielded a 
white solid (5.7 g, 62%) m.p. 278-280°C. (Lit.^°^ 280-282°C).
Preparation of N-benzyloxycarbonyl-aminobenzylphosphonic acid
Aminobenzyl phosphonic acid (2 g, 10.6 mmol) in water (12 ml) 
was added to benzyloxycarbonyl chloride (2.46 g, 16 mmol) in 
ether (12 ml). The stirred mixture was kept between pH 9-9.5 
by addition of 4M NaOH over a period of 9 hrs. The mixture 
was stirred for a further 8 hrs. The ether layer was discarded and 
the aqueous phase was poured onto water (30 ml), concentrated 
sulphuric acid (30 ml) and ice (100 g). This was then 
exhaustively extracted with ether. The ether was removed in 
vacuo to yield a white solid (1.35 g, 42%).
122.
Attempted Coupling of N-benzyloxycarbonyl-aminobenzylphosphonic 
acid with phenylglycine methyl ester. Identification of 
product ( 1 2 5 )
N-Benzyloxycarbonyl aminobenzylphosphonic acid (0.94 g,
3 mmol) in dimethyl formamide (50 ml) was treated with freshly
distilled pivoyl chloride (0.73 g, 6 mmol) and N-methyl morpholine
o o(0.61 g 6 mmol) at -23 C. The mixture was stirred at -23 C
for 1 hr. Phenylglycine methyl ester hydrochloride (0.51 g,
3 mmol) and N-methyl horpholine (0.61 g, 6 mmol) were added to
the stirred mixture. The reaction mixture was allowed to warm
to room temperature and stirred for 8 hrs. The solvent was
removed in vacuo and the resulting residue dissolved in
chloroform and washed with water. The organic solution was
dried over magnesium sulphate, filtered and the solvent removed
in vacuo to yield a yellow oil. Chromatography on silica ,
eluting with ethyl acetate, yielded a colourless gum (1.23 g )
This was shown to be N-tert Uutyloxyphenylglycine methyl ester
(125). 6 ^ (lOOMHz:CDClg) 1.2 (9H, s, (CH^)^), 3.64 (3H, s,
OCHg), 5.46 (IH, s, CH), 6.66 (IH, br d, NH), 7.2 (5H, m,
aromatic); 6^ (CDCl^) 27.5 (CH^), 38.7 (-CCCHg)^), 56.5
(CH), 52.6 (OCH^), 127.20, 128.45, 128.99, 136.95 (aromatic),
171 (CONH), 177 (COgMe); m/z 249 (M^).
123.
1-Hydroxymethyl phthalimide
A suspension of phthalimide (102.2 g, 0.7 mol) and 40% 
formaldehyde (52 ml) in water (350 ml) was heated at reflux 
until the solution turned clear. The mixture was heated at 
reflux for a further 1 hr and then cooled to room temperature. 
The solution was kept at 0°C overnight and a white solid 
crystallised from the solution. The resulting solid was 
filtered, washed with water and recrystallised from methanol/ 
water to yield a white crystalline material (113.9 g, 92%) 
m.p. 138-140°C (Lit.^^37-141°C) .
1-Bromomethyl phthalimide
A suspension of hydroxymethylphthalimide (30.6 g, 0.2mol) in
chloroform (300ml) was stirred and heated gently at reflux.
Dry hydrogen bromide was bubbled through the stirred mixture via
a submerged glass inlet at a moderate rate for 2 hrs. After a
short period (20 min.) the mixture became homogeneous and
eventually turned orange. The solution was poured (whilst still
warm) into a separating funnel and the lower aqueous hydrogen
bromide layer discarded. The organic layer was washed. with
warm water (2 x 200 ml). The organic solution was dried over 
magnesium sulphate, filtered through celite and the solvent
removed in vacuo to yield a white crystalline solid.
Recrystallisation from chloroform yielded a colourless





Bromomethyl phthalimide (23 g, 0.096 mol), freshly 
distilled trimethyl phosphite (12.45 ml, 0.096 mol) and 
redistilled xylene (200 ml) were heated gently under nitrogen for 
30 mins. The temperature was gradually raised to reflux and the 
mixture heated at reflux for 5 hrs. Some of the solvent (150 ml) 
was then distilled away, and the remaining solution was allowed 
to cool overnight. The crystalline product was washed with 
ether and dried in vacuo to yield a white solid (24.44 g, 91%). 
m.p. 117-118°C (Chloroform-caroon tetrachloride) Lit. m.p 117.5- 
119°C.
0-Methyl phthalimidomethyl phosphosphonic acid (135)
Dimethyl phthalimidomethyl phosphonate (2.69 g, 10 mmol), 
in dry toluene (20 ml) was heated at reflux with phosphorus 
pentachloride (2.08 g, 10 mmol) for 5 hrs. The solvent was 
removed in vacuo and the resulting solid stirred overnight 
with acetone/water 9:1 (20 ml). The solvents were removed 
under reduced pressure and the resulting solid washed with 
chloroform to yield a white solid. (1.99 g, 78%); m.p. 142- 
144 C (from methanol); (Found: C, 47.05, H, 3.95; N 5.49;
P, 12.14. C^QH^^NO^P requires C, 46.95; H, 4.13; N, 5.45;
P, 11.98). (Nujol) 3500-2700 (P-OH), 1780, 1720 (0=0),
1600 (aromatic), 1215 (P-OCH^), 1020 (P=0); 6^ (60MHz : (CD^ )2S0)
3.6 (3H, d, J llHz, POCH ), 3.9 (2H, d, llHz, CH P),PH o PH 6
6.7 (IH, hr s, POH), 7.8 (4H, m, aromatic); 6
24.5 and 31.2 (CH^P, 149Hz), 53.62 and 53.92 (POCH^,
Jçp 6.1Hz), 116.96, 125.5, 128.4 (aromatic), 160.5 (C=0);
m/z (M+1) 256 [+] ion FAB (M-1) 254 [-] ion FAB.
125.
Attempted preparation of N - [[[(phthaloyl)aroino]methyl! 
methoxyphosphinyl]-L-phenylalanine methyl ester.
Isolation of N-diethoxyphenyl phenylalanine methyl ester (129).
0-Methyl phthalimidomethyl phosphonic acid (510 mg, 2 mmol) 
was treated with diethyl chlorophosphate (0.3 ml, 2 mmol) and
N-methyl morpholine (0.2 ml, 2 mmol) in dry tetrahydrofuran at
o o-20 C. The mixture was stirred at -20 C for 30 mins.
Phenylalanine methyl ester hydrochloride (430 mg, 2 mmol) and
N-methyl morpholine (0.2 ml, 2 mmol) were added to the stirred
mixture. The reaction mixture was allowed to warm to room
temperature and stirred for 8 hrs. Insoluole materials were
filtered and the solvent removed in vacuo to yield a yellow
gum. Chromatography on silica eluting with ethyl acetate
yielded a colourless gum (610 mg). This was shown to oe
N-diethoxyphosphonyl phenylalanine methyl ester (129).
6 ̂  (100MHz:CDClg) 1.25 (6H, m, OCH^CH^), 3.05 (2H, br m,
CH^Ph), 3.67 (3H, s, OCH^), 3.9 (5H, m, POCH^ and CH). 7.25— z o — A
(5H, m, aromatic) 7.8 (IH, or, NH); 6 ^ (CDCl^) 15.98, 16.31 
(CHg), 40.58, 40.85 (gigPh) 52.06 (OCH^), 55.85 (CH), 62.41 
and 62.63 (POCH^, J^p 4.78Hz), 123.63, 127.04, 128.56,
129.56, 136.36 (aromatic), 173.09 (C=0).
126.
N- [ [ [( Phthaloyl )amino]methyl Imethoxyphosphinyl ]-L-phenylalanine
methyl ester (136).
Phthalimidomethyl dimethyl phosphonate (19.51 g, 0.0725mmol)
in dry toluene (150 ml) was heated at reflux with phosphorus
pentachloride (16.61 g, 1.1 eq) for 5 hrs. The solvent was
removed in vacuo and the oily residue was dissolved in dry
ethanol free chloroform (50 ml). This was added dropwise to
a chloroform solution of L-phenylalanine methyl ester hydrochloride
(15.09 g, 0.07 mol) and triethylamine (21.18 ml , 2.1 eq) at 0 C.
The solution was allowed to warm to room temperature and stirred
for 8 hrs. The mixture was diluted with chloroform (50 ml)
and washed with IM sodium dihydrogen phosphate (2 x 150 ml),
saturated sodium bicarbonate (2 x 100 ml) and water (2 x 100 ml).
The organic solution was dried over sodium sulphate, filtered
and the solvent removed in vacuo to yield a yellow oil. 
Chromatography on silica eluting with petroleum ether/
ethyl acetate 1 ;1 yielded a white solid (6.87 g, 23%).
(Found: C, 56.7; H, 5.0; N, 6.6; P, 6.9. C. H N O^P.^H^O
^ vj ^ J. ^ O 6
requires C, 56.5; H, 5.2; N, 6.6; P, 7.3); v (CHCl^)max o
3400 (NH), 2950 (CH), 1780, 1720 (C=0), 1600 (aromatics),
1380 (OCHg), 1250 (P-OCH^), 1045 (P=0) cro"^;
<5̂  (400 MHz; CDCl^ ) 3.02-3.12 (2H, ro, CH^Ph), 3.41 (IH, br t,
PtNH), 3.61 (3H, d, llHz, POCH^), 3.68 (3H, s, CO^CH^),
3.7 (IH, dd, J llHz, CH -P), 3.95 (IH, dd, J llHz, CH P),X n ij
4.4 (IH, m, CHCHgPh), 7.2 (5H. m, Ph), 7.8-7.9 (4H, m, F+);
(CDCl^) 23 (IP, m); (CDCl^) 32.13 and 38.41 (CH^P,
J^p 141.6 Hz), 40.47 (CH^Ph), 52.17 (OCH^), 52.98 (CHCH^),
54.72 and 54.93 (P-OCH„, J 5.8Hz), 123.41, 126.88, 128.40,
^ CP
129.53, 134.14, 131.91, 136.30 (aromatics), 157.18 (CO^CH^),
173.19 (-CONH); m/z 417 (M+1), 357, 325, 269, 238, 160 (base).
127.
N- [ [ [(Phthaloyl )ainino]roethyl]roethoxyphosphinyll -L-glycine
methyl ester (140).
Phthalimidomethyl phosphonic acid (138) (122 mg, 0.51 mmol)
was heated at reflux with excess thionyl chloride (5 ml) for
48 hrs. The excess thionyl chloride was removed in vacuo.
Traces of thionyl chloride remaining were removed oy dissolving
the residue in dry ethanol-free chloroform and removing the
solvent under reduced pressure. The resulting white solid
was dissolved in dry ethanol free chloroform and stirred at 0°C
with glycine methyl ester hydrochloride (58.91 mg, 0.51 mmol) and
triethylamine (103 mg, 1.02 mmol). The stirred solution was
allowed to warm to room temperature and stirred for a further
5 hrs. To the stirred mixture dry methanol (1 ml) and
triethylamine (52 mg, 0.51 mmol) were added. The reaction
mixture was stirred for a further 8 hrs; washed with water 
(2 X 5 ml), dried over magnesium sulphate, filtered and the
solvent removed in vacuo to yield a white paste.
Chromatography on silica eluting with chloroform/ethanol
(9:1) yielded a white paste (27 mg, 16%). (Found:
326.0651 CL^H^^N^O^P requires M, 326.0668); v (CHC1„)Xo X V 6 O ID&X 3
3370 (NH), 2950 (CH), 1780, 1710 (CONCO), 1750 (CO^Me),
1410 (OMe), 1220 (P-OCH^), 1140 (P=0) cm"^; 6^(100MHz:CDCl^)
3.73 (2H, s, CHg), 3.76 (3H, s, CO^CH^), 3.82 (3H, d, 11 Hz,
P-OCH_), 4.10 (2H, d, llHz, CH^P), 4.42 (IH, Or, NH), 7.80
(4H, m, aromatic); m/z 326 (M^), 294,238, 160 (oase).
128.
N-BenzyloxycarDonylglycyl-aminomethyl(niethoxyphosphinyl )-L-
phenylalanlne methyl ester (142).
Crude aminomethyl(methoxyphosphinyl )-L-phenylalanine methyl
ester (510 mg, 1.8 mmol) in dry tetrahydrofuran (25 ml) was
added to a stirred solution of O-benzyl-N-oenzyloxycarbonyl-
glycine (455 mg, 2 mmol) and dicyclohexyl caroodiimide (DCC)
(0.5 g, 2.16 mmol) in tetrahydrofuran (25 ml) at 0°C.
The mixture was allowed to wprm to room temperature and stirred
for 72 hrs. The precipitated dicyclohexyl urea was filtered and
the solvent removed in vacuo. The resulting oil was dissolved
in ethyl acetate (25 ml) and washed with saturated sodium
bicarbonate (2 x 20 ml), water (2 x 20 ml) and saturated sodium
chloride (2 x 20 ml). The organic solution was dried over
sodium sulphate, filtered and the solvent removed in vacuo to 
yield a pale yellow oil. Chromatography on silica eluting
with ethyl acetate yielded (142) as a colourless gum (485.mg, 56%)
(Found: C, 54.44; H, 5.97; N, 8.78. S2^28^3°7^*^^2°
requires C, 54.27; H, 6.01; N, 8.64%); v (CHCl^)max 3
3400 (NH), 2950 (CH), 1690-1750 (C=0), 1600 (aromatic), 1450
(OCH_), 1200 (P-OCH_), 1050 (P=0)cm"^; (400MHz:CDCl^)o o H 3
2.83 (IH, m, CH H Ph), 3.08 (IH, m, CH H Ph), 3.19 (3H, d,~A M A~M
J ll.lHz, P-OCH ), 3.28 (IH, m, CH H P), 3.65 (IH, m, CH H P),
X ii O  ft D  A  Jd
3.72 (3H, s, CO CH ), 4.05 (IH, octet, CH CH CH Ph), 4.16 (IH, t,^ o X A M
P-NH), 5.10 (2H, s, OCH^Ph), 6.05 (IH, br t OCONH), 7.15-7.33
— z  —
(lOH, m, aromatic), 7.58 (IH, br t, CONH); A (CDCl^),
34.93 and 36.40 (CH^P, 146.92Hz), 40.28, 40.33 (CH^Ph),
44.13 (CHgCO), 50.64 and 50.57 (P-OCH^, 6.73Hz), 52.35
(COgCHg), 55.21 (CHCHgPh), 66.82 (CH^OPh), 126.97, 127.9, 128.3, 
128.49, 129.37, 136.18, 136.38 (aromatic), 156.33 (OCONH),
169.29, 169.34 (CO^Me), 173.68 (CONH); m/z,500 (M+Na), 478 
(M+1) [+] ion FAB.
129.
0-Benzyl-N-benzyloxycarbony1-L-tyrosy1-glycyl-aniinoroethy1 
(methoxyphosphinyl)-L-phenylalanine methyl ester (143)
Crude aminomethyKmethoxyphosphinyl )-L-phenylalanine 
methyl ester (510 mg, 1.8 mmol) in dry tetrahydrofuran (25 ml) 
was added to a stirred solution of 0-benzyl-N-benzyloxycaroonyl- 
tyrosyl-glycine (800 mg, 2 mmol) and dicyclohexylcarbodiimide 
(DCC) (500 mg, 2.16 mmol) in tetrahydrofuran (25 ml) at 0°C.
The mixture was allowed to warm to room temperature and stirred 
for 72 hrs. The precipitated dicyclohexylurea was filtered and 
the solvent removed in vacuo. The resulting oil was dissolved 
on ethyl acetate (25 ml) and washed with saturated sodium 
bicarbonate (2 x 20 ml), water (2 x 20 ml) and saturated 
sodium chloride (2 x 20 ml). The organic solution was dried over
sodium sulphate, filtered and the solvent removed in vacuo to 
yield a pale yellow oil. Chromatography on silica eluting 
with ethyl acetate yielded a foam (730 mg, 55%). (Found;
C, 61.87; H, 5.99; N, 7.93. C^gH^^N^O^P.^H^O requires 
C, 61.68; H, 5.99; N, 7.58%); v (CHCl^) 3370 (NH),IDâ.7C o
2850 (CH), 1720, 1640 (C=0), 1610 (aromatic), 1480 (OCH^)
1250 (P-OCHg), 1050 (P=0)cm“^; 6 ^  (400MHz;(CD^)2S0) 2.98
(2H, m, CH H, Ph and C ^ ’H ’Ph), 3.16 (2H, m, CH H Ph and —A M M A—M
CH'H ’Ph), 3.30 (2H, m, CH_P), 3.38 (3H, d, 11.1 Hz,A“M A Pn
P-OCHg), 3.61 (3H, s, COgCHg), 3.77 (2H, m, CH CO), 4.15 (IH, 
octet, CH^CH^Ph, 4.40 (IH, octet, CH^’Tyr), 4.93 (2H, q,
PhCHgO, J 11.8Hz), 4.98 (2H, s, PhOCH^), 6.81 (2H, dd,
^Ax G'GlHz), 7.13 (2H, dd, 8.59Hz), 7.15-7.31 (15H, m,
aromatic), 7.55 (IH, t d, NHCH^P), 8.10 (IH, t, NHCH^);
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6 _ ((CD ) SO) 35.23 and 35.57 (CH P, J 146.15Hz), 40.78 
(CHgPh), 48.71 and 48.78 (P-OCH^, 6.91Hz), 50.17 (NHCH^CO),
53.57 (COgCHg), 54.87 (CHCH^Ph), 64.15 (PtiCH^OCO), 67.86 
(PnCHgO), 112.78, 124.94, 125.75, 125.88, 126.03, 126.55, 
126.68, 127.75, 128.30, 128.57, 135.10, 135.47, 154.37 
(aromatic), 155.48 (OCONH), 166.99 (CO^CH^), 170.21, 171.61 
(CONH); m/z 753 (M+Na), 731 (M+1) [+] ion FAB.
131.
N- [ [ [(Phthaloyl)amino]methyl]methoxyphosphinyl]-L-phenylalanyl
-L-Leucine methyl ester (144)
Phthalimidomethyl dimethylphosphonate (2.1g, 7.8 mmol) in
dry toluene (50 ml) was stirred with phosphorus pentachloride
(1.8 g, 1.1 eq). The mixture was heated at reflux for 5 hrs.
The solvent was removed in vacuo to yield a yellow gum.
This was dissolved in dry tetrahydrofuran and added to a stirred
solution of phenylalanyl leucine methyl ester hydrochloride
(2.55 g, 7.8 mmol) and N-methyl morpholine (1.9 ml, 2.1 eq).
The mixture was allowed to warm to room temperature and stirred
for 8 hrs. The precipitated N-methyl morpholine hydrochloride
was removed by filtration. The solvent was removed in vacuo
to yield a yellow oil. The oil was dissolved in ethyl acetate
and washed with water (2 x 40 ml), 5% citric acid (2 x 50 ml),
5% sodium bicarbonate (2 x 50 ml) and water (1 x 50 ml). The
solution was dried over magnesium sulphate, filtered, and the
solvent removed in vacuo to yield a yellow oil. Chromatography
on silica eluting with ethyl acetate yielded a pale yellow gum
(1.31 g, 32%) which solidified on standing, MeOH 35.5 ;
(Found: C, 58.5; H, 6.1; N, 8.0. ^26^32^3^7^ requires
C, 58.94; H, 6.09; N, 7.93); V (CHCl^) 3370 (NH), 2950 (CH),max j
1780 (CONCO), 1750 (CO^Me), 1730 (CONCO), 1650 (CONH), 1620
— 1(aromatic), 1400 (OCH^), 1250 (P-OCH^), 1050 (P=0)cm ;
ÔH ( 400MHz : CDClg ) 0.86 (3H, br t, CH^),0.91 (3H, br t, CH^),
1.57 (2H, br d, -CHCH^), 3.10 (IH, m, CH^H^Ph), 3.15 (IH, m, 
CH^H^Ph), 3.42 (IH, dd, P-NH), 3.62 (1.8H, s, CO^Me), 3.66 
(1.2H, s, COgMe) minor diasteroisomer, 3.48 (1.2H, d,
llHz, P-OCHg), 3.80 (1.8H, d, llHz, POCH^), 3.85 (0.4H,
dd, llHz, CH^H^P), 3.95 (0.6H, dd llHz, CH^H^P),
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4.05 (0.4H, dd, HHz, CH^H^P), 4.15 (0.6H, dd
llHz, CH^H^P), 4.25 (IH, m, NHCH), 4.55 (IH, m, NHCH),
7.3 (5H, nj, aromatic), 7.65 (IH, Dr, CONH) 7.72 (2H, m,
aromatic), 7.80 (2H, m, aromatic); 6^ (CDCl^) 22.78, 22.81
(CHg), 24.70 (CHMe^), 32.29 and 40.03 (CH^P, J^p 174.56Hz),
40.19 (CHgCH), 40.96 (CH^Ph), 50.92 (CHCH^),
51.81 and 51.57 (P-OCH^, 6.1Hz), 52.11 (OCH^), 56.12—  o CP — 3
(CHCHgPh), 123.57, 126.93, 128.56, 129.69, 131.86, 134.30, 
136.68 (aromatic), 167.40 (CO^Me), 171.84, 172.06 (CONCO), 
173.14 (CONH); m/z 530 (M+1), 498 (M-OMe), 293 (base).
133.
O-Eenzyl-N-benzyloxycarbonyl-L-tyrosyl-glycyl)-aminoniethyl
(methoxyphosphinyl)-L-phenylalanyl-L-leucine methyl ester (145).
0-Benzyl-N-benzyloxycarhonyltyrosyl-glycine (780 mg, 1.7 mmol)
in dry dimethyl formamide (40 ml) under argon at -25°C was
treated with diphenylphosphinyl chloride (DPPCl) (0.4 g, 1.7 mmol).
oThe mixture was stirred at -25 C for 15 mins. A dimethyl
formamide solution containing crude aminomethyl(methoxyphosphinyl)
-L-phenylalanine methyl ester (700 mg) was added to the stirred
solution at -25°C. N-Methyl morpholine (0.19 ml, 1.7 mmol)
was added to the stirred mixture. The mixture was allowed
to warm to room temperature and stirred for 8 hrs. The solvent
was removed in vacuo and the resulting oil dissolved in ethyl
acetate (75 ml). The organic solution was washed with water
(2 X 25 ml), 5% citric acid (2 x 25 ml), 0.5M potassium carbonate
(2 X 25 ml), water (2 x 25 ml) and saturated sodium chloride
(2 X 25 ml). The organic solution was dried over sodium
sulphate, filtered and the solvent removed in vacuo to yield (145) as a
colourless gel (540 mg, 34%). Preparative thin layer
chromatography eluting with chloroform/methanol (95:5) yielded
a colourless foam. Amino acid analysis, glycine 1.01, leucine
0.92, tyrosine 0.97, phenylalanine 0.91; 5 ^ (400MHz:(CD^)2S0)
0.83 (6H, m, (CHg)^), 1.55 (2H, m, CHCH^), 1.62 (IH, m, CH^CH),
2.98 (2H, m, CH H Ph and CH 'H ’Ph), 3.14 (2H, m, CH H Ph and nr-x m -X -m x
CH ’H ’Ph), 3.54 (IH, dd, P-NH), 3.58 (3H, d, llHz, P-OCH_),
— m  X  P n  o
3.64 (3H, s, CO^CH^), 3.82 (2H, br m, NHCH^CO), 3.85 (IH, dd,
'̂ PH 4-00 (IH, dd, Jp^ llHz, CH^H^P), 4.15 (IH, m,
CHCHg), 4.55 (2H, m, CH^CH^Ph and CH^’Tyr), 4.98 (2H, s, PhOCH^),
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5.02 (2H, q, CH^OCO), 5.60 (IH, Dr, NHCO), 7.15-7.42 (15H, 
m, aromatic), 6.85 (2H, dd, 8.6Hz), 7.05 (2H, dd
8.6Hz), 7.90 (IH, Dr, NHCH^CO); m/z 866 (M+Na), 844 (M+1)
[+] ion FAB.
Attempted deprotection of Q-benzyl-N-benzyoxycarbonyl-L-tyrosyl- 
glycyl-aminome thy1(me thoxypho sphiny1)-L-phenylalanyl-L-1eue ine 
methyl ester.
a) The protected pentapeptide (145) (175 mg, 0.2 mmol) in 
methanol (10 ml) was stirred with ammonium formate (50 mg) and 
10% Palladium on charcoal (10 mg). After 5 mins the starting 
material had disappeared and a major product that sprayed positive 
with ninhydrin was present. This was shown by t.l.c. to be 
phenylalanyl leucine methyl ester.
b) The protected pentapeptide (145) (230 mg, 0.27 mmol) in dry 
dichloromethane was treated with bromotrimethylsilane (TMSBr)
(5 eq, 0.21 ml). The mixture was stirred at room temperature 
for 8 hrs. The dichlorome thane was removed in vacuo to yield
a yellow gum which was dissolved in acetone/water (9:1) (20 ml) 
and the mixture stirred for 2 hrs. The solvents were removed 
in vacuo to yield a pale yellow gum. Reverse phase chromatography
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eluting with methanol/water (70:30) yielded a colourless gum 
(50 mg). T.l.c. showed this gum to contain a major product 
that sprayed positive with ninhydrin, indicating a free amino 
function. n.m.r. showed this to be a mixture of products.





Phthalimidomethyl dimethyl phosphonate (269 mg, 1 mmol)
was stirred at room temperature with sodium oorohydride (21 mg,
1.1 mmol) in propan-2-ol (20 ml) and water (2 ml). The
mixture was stirred at room temperature for 2 hrs. Acetic
acid (2 ml) was added dropwise and when the foaming suDsided
the mixture was stirred at room temperature for a further
30 mins. Water (20 ml) was added to the mixture and the
aqueous system extracted with dichloromethane (2 x 20 ml).
The organic solution was dried over magnesium sulphate, filtered
and the solvent removed in vacuo to yield a colourless oil.
Chromatography on silica eluting with ethyl acetate yielded a
colourless gum (212 mg, 79%). (Found; 271.0580
C,,H, NO^P requires M, 271.0609); ^ 3350 (OH), 1700 (C=0),11 14 5 max
1230 (P-OCHg), 1050 (P=0) cm"^; (lOOMHz:CDCl^) 3.75 (6H,
2 X  d, llHz, P-OCH ), 4.05 (2H, dd, J_„ llHz, CH P), 6.05PH o PH 6
(IH, s, CHOH), 7.4-7.8 (4H, m, aromatics); 6 (CDCl^) 30.34-
and 37.3 (CH P, J 157.5 Hz), 52.93 and 53.29 (P-OCH , J6 L/ir O
7.33Hz), 53.09 and 53.36 (P-OCH^, 6.11Hz), 81.9 (CHOH),
123.30, 123.57, 128.56, 129.59, 130.83, 132.51 (aromatics),
167 (C=0); m/z 271 (M^), 162, 133 (base).
l-(l-Hydroxy-3-oxo-2H-isoindol-2-yl)methyl -(methoxy- 
phosphinyl-L-phenylalanyl-L-leucine methyl ester (158).
N- [ [ [( Phthaloyl)amino]methyllmethoxyphosphinyl ]-L- 
phenylalanyl-leucine methyl ester (300 mg, 0.57 mmol) was stirred 
at room temperature with sodium oorohydride (12 mg, 0.63 mmol)
137.
in propan-2-ol (20 ml) and water (2 ml). The mixture was 
stirred at room temperature for 2 hrs. Acetic acid (2 ml) 
was added dropwise and when foaming subsided the mixture was 
stirred at room temperature for a further 30 mins. Water 
(20 ml) was added to the mixture and the aqueous system 
extracted with dichloromethane (2 x 20 ml). The organic 
solution was dried over magnesium sulphate, filtered and the 
solvent removed in vacuo to yield a colourless oil.
Chromatography on silica eluting with ethyl acetate yielded 
a colourless gum (265 mg, 87%); ^max (^HCl^) 3350 (OH),
1680-1700 (CONH), 1740 (CO^CH^), 1250 (P-OCH^), 1050 (P=0) cm"^;
6^ (lOOMHz;CDClg) 0.85 (6H, br, CH(CH^)^, 1.48 (3H, br, CH^CH),
3.08 (2H, m, CH^Ph), 3.43 (2H, dd, llHz, CH^P), 3.62 (3H, s,
COgCH^), 3.65 (3H, d, llHz, P-OCH^), 3.8 (2H, m, NHCHCO),
3.45 (br, OH), 5.9 (IH, d, CHOH), 7.0-7.8 (9H, m, aromatic)
Ô (CDC1_) 21.72, 22.81 ((CH_)_), 24.70 (CH(CH„)„), 29.68 and 34.13U O 6 O 6
(CHgP, J^p lOOHz), 40.52 (CH^CH), 41.01 (CH^Ph), 50.97 (NHCHCO)
51.03 and 51.36 (P-OCH^, J^p 7.1Hz), 52.23 (CO^CH^), 56.29,
56.67 (NHCHCO), 82.45, 82.72 (CHOH), 123.36, 123.57, 126.99,
128.26, 128.72, 129.59, 129.80, 131.05, 132.46, 136.79, 144.38, 
144.48 (aromatic), 167.62 (CO^Me), 173.25 (CONH); m/z 532 (M+1)
[+] ion FAB, 530 (M-1) [-1 ion FAB.
138.
Deprotection of N,N’(2,2*-dibenzyl-l-aminomethyl)dimethyl 
phosphonate (159)
N,N'(2,2'-Dibenzyl-l-aminomethyl)dimethyl phosphonate (400 mg) 
in 4.4% formic acid in methanol (5 ml) was added to palladium 
black (400 mg) in 4.4% formic acid in methanol (10 ml). The 
mixture was continually stirred under an argon atmosphere for 
15 hrs. T^e catalyst was filtered and washed with water (5 ml) 
and methanol (5 m l ) . The solvents were removed in vacuo to yield 
a colourless oil. The oil was redissolved in methanol/water 1:1 
and put in the freezer. A  product shown to be (160) crystallised 
out (110 mg, 70%). <5 ^(looMHzrD^O) 3.10 (2H, d, 12Hz,
CH^P), 3.58 (3H, d, lOHz, P-OCH^); ^ (D^O) 31.91 and
38.30 (CH^P, Jç,p 144Hz), 52.98 and 53.25 (P-OCH^, 6.lHz); 
m/z [+] ion FAB 126 (M+1); [-] ion FAB 124 (M-1).
139.
N,N'(2,2'-Diallyl-l-amimomethyl)dimethylptiosphonate (161 )
N,N'-Diallylamine (18.33 ml), dimethyl phosphite (24.7 ml, 
1 eq) and 40% formaldehyde solution (40 ml) were stirred at 
room temperature for 10 hrs. Water and any unreacted starting 
materials were removed on a cold finger to yield a yellow oil. 
Bulb to bulb distillation yielded a yellow oil (40 g, 91%). 
b.p. 145°C at 0.2mm. (Found; 219.1024. C^H^gNO^P
requires M, 219.1024); v (neat) 3100-2700 (CH), 1640ioâ.x
(C=C), 1440 (OCHg), 1250 (P-OCH^), 1050 (P=0) cm“^;
5^ (lOOMHz; CDCl^) 2.90 (2H, d, 12Hz CH^P), 3.26 (2H,
d, CH^N), 3.78 (6H, d, 12Hz, P^OCHg)^), 5.2 (4H, m, H^Cz:),
5.75 (2H, m, =CH-); 6^ (CDCl^) 43.99 and 51.19 (CH^P,
162.35Hz), 52.5 and 52.77 (POCH^, J^p 6.1Hz), 57.91 and 
58.29 (CHgN, J^p 9.54Hz), 118.21 (HgC=), 135.0 (=CH-); 
m/z 219(M^), 204, 192, 110 (oase), 68, 41, 28.
140.
2-(Hydroxymethyl)-l-[Hi-isoindol-l-oxo-S,(2H)-thione
Monothiophthalimide (150 mg, 0.92 mmol) in 40% aqueous
formaldehyde (7.5 ml) and water (25 ml). The mixture was
heated at reflux for 5 hrs and then extracted with ethyl
acetate (2 x 20 ml) and the solvent removed in vacuo to yield
a pink solid. Chromatography on silica eluting with
dichlorome thane/ethyl acetate (3:1) yielded a pink solid
(145 mg, 82%) m.p. 117-119°C (from toluene). (Found: M
193.0164 CqH^NO_S requires, M 193.0197); v (CHC1_) y / z max j
3480 (OH), 1710 (C=0), 1600 (aromatic), 1350 (C=S);
X (EtOH) 327 ( G 5942), 290 (e 7,971), 231 (e 16,908);
6 jj (60MH z :CD20D), 5.00 (IH, br s, OH), 5.32 (2H, s, CH^),
7.65 (4H, m, aromatic); 6 (CD^OD) 63.71 (CH^OH), 123.9, 
124.33, 124.81, 134.95, 135.59 (aromatic), 168.97 (C=0), 
198.44 (C=S); m/z 193 (m "̂ ) , 163 (base), 103, 76, 28.
141.
2-(Bromomethyl-1- -Isoindole-l-oxo-3, (2H )-thione
2-(Hydroxymethyl-Isoindole-l-oxo-3,(2H)-thione 
(120 mg, 0.62 mmol) in dry dichloromethane (15 ml) at room 
temperature was stirred with phosphorus trioromide (59 yl,
0.62 mmol) for 3 hrs. The organic solution was washed twice 
with water (2 x 5 ml) dried over sodium sulphate, filtered and 
the solvent removed in vacuo to yield a pink solid. 
Chromatography on silica eluting with dichloromethane yielded
a pink crystalline solid (120 mg, 76%) m.p. 109-111 C;
+ 79(Found: M 254.9355 C^H^NOS Br requires M, 254.9353,
Found: 256.9333 C^H^NOS^^Br requires M, 256.9333);
V (CHC1„) 3000 (CH), 1740 (C=0), 1600 (aromatic),max 3
1350 (C=8), 1150 (C-Br)cm"^;  ̂ (EtOH) 324nm (e 12,179),max
286nm (e 16,026), 231nm ( E 31,410); 6 (60MHz:CDC1_)
5.77 (2H, s, CHgBr), 7.83 (4H, m, aromatic); <5̂  (CDCl^)
34.35 (CHg), 123.79, 124.55, 127.51, 134.30, 135.17, 137.93 





2“(Bromomethyl )-l-(H ]-Isoindole-l-oxo-3-thio-2(H )-thione
(100 mg 0.35 mmol) in dry xylene (10 ml) was heated at reflux with
excess trimethylphosphite (3 ml) for 10 hrs. The solvent was
removed in vacuo and the crude mixture chromatographed on silica
eluting firstly with dichloromethane to remove any unreacted 
starting material. The product was eluted with
dichloromethane/ethyl acetate (75:25). The solvents were
oremoved to yield a pink crystalline solid m.p. 103-104 C.
(Found; 285.0224. C^^H^gNO^PS requires M, 285.0235);
V (CHCl^) 2950(CH), 1680 (C=0), 1600 (aromatics),max 3
14CX) (OCHg), 1340 (C=S), 1200 (P-OCH^), 1050 (P=0) cm"^; '
X (EtOH), 327nm ( e 7,143), 290nm ( E 12,054), 231nmmax
( e33,929); 6^ (60MHz; CDCl^ ) 3.37 (2H, d, llHz, CH^P),
3.65 (6H, d, Jp^ llHz, PCOCHgXg), 7.56 (4H, m, aromatic);
6^ (CDCl^) 32.4 and 39.33 (CH^P), J^p 157.25 Hz), 53.04 and 
53.25 (P-OCH^, J^p 4.89 Hz), 123.08, 124.22, 126.99, 133.43,
134.35, 137.28 (aromatic), 168.65 (0=0), 195.52 (C=S); 
m/z 285 (m "̂ ), 189, 176 (hase).
143.
2-(Hydroxymethyl)-l[H]-Isoindole-1,3,(2H)-dithione
Dithiophthalimide (179mg, Iromol) was heated at reflux in 
40% aqueous formaldehyde (7.5ml) and water (25 ml). The mixture 
was refluxed for 8 hrs, cooled to room temperature and extracted 
with ethyl acetate (2 x 20 ml). The organic layer was dried 
over sodium sulphate, filtered and the solvent removed in vacuo 
to yield a Drown solid. Chromatography on silica eluting with 
dichloromethane yielded a red crystalline solid (153 mg, 74%) 
m.p. 118-120°C (from toluene). (Found; C, 51.46; H, 3.48;
N, 6.69. CgHyNOSg requires C, 51.7; H, 3.4; N, 6.7%);
V (CHCl^) 3580(0H), 1600 (aromatic), 1350 (C=S)cm"^; max 3
X (EtOH) 377nm ( e 33,800), 240nm (e 22,154); max
6^ (60MHz; CDCl^) 3.3 (IH, br s, -OH exch. D^O), 5.7 
(2H, s, CHg) 7.4-7.9 (4H, m, aromatic); <S ^(CD^COCD^) 66.41 
(CHg), 124.11, 134.78, 135.67 (aromatic), 197.65 (C=S); 




0.38 mmol) in dry dichloromethane (15 ml) at room temperature
was stirred with phosphorus trioromide (36y 1, 0,38 mmol) for
3 hrs. The organic solution was washed twice with water
(2 X 5 ml) dried over sodium sulphate, filtered and the solvent
removed in vacuo to yield a clack solid. Chromatography on
silica eluting with dichloromethane yielded a clack crystalline
solid (47 mg, 45%) m.p. 109-111°C (from toluene). (Found:
C, 40.09; H, 2.25; N, 5.29; S, 23.13; Br, 29.30.
C^HgNSgBr requires C, 39.85; H, 2.21; N, 5.16; S, 23.66;
-1Br, 29.48%); v (CHCl.) 1600 (aromatic), 1350 (C=S) cm ;
1D8.X O
X (EtOH) 355nm ( e 18,700), 250nm ( £20,400);max
Ô ^(60MHz:CDClg) 6.05 (2H, s, CH^Br), 7.4-7.8 (4H, m, aromatic); 
5 (CDClg) 36.95 (CH^Br), 123.57, 133.81, 135.33 (aromatic),




2“(Bromomethyl)-l- [H]-Isoindol-l,3,2(H)-dithione (136 mg,
0.5 mmol) in dry xylene (20 ml) was heated at reflux with
trimethylphosphite (60 y 1, 1.1 eq) for 8 hrs. The solvent was
removed in vacuo and the crude mixture chromatographed on silica
eluting firstly with dichloromethane to remove any unreacted
starting material. The product was eluted with dichloromethane/
ethyl acetate (75:25). The solvents were removed to yield a
dark red solid (70 mg; 47%) m.p. 106-107^0 (from toluene).
(Found: m '*’, 300.9968. C^^H^gNO^PSg requires M, 300.9996);
V (CHC1_) 3,000 (CH), 1600 (aromatic), 1350 (C=S), max o
1200 (P-OR), 1050 (P=0) cm~^; X (EtOH) 355nm (e 19,095),max
245nm (e 17,085); <5 ^(lOOMHz ; CDCl^) 3.72 (6H, d, llHz,
P^OCHg)^), 5.94 (2H, d, -2Hz, CH^P), 7.5-7.9 (4H, m, aromatics);
6^ (CDClg) 28.39 and 35.70 (CH^P. 146.48Hz), 52.87 and
53.15 (P-OCH^, J^p 6.94Hz), 123.4, 133.32, 134.68 (aromatic),
195.95 (C=S); m/z 301(M^), 268, 205 (oase), 192, 164, 146,
120, 93.
146.
Thionation of N-CarPethoxyphthalimide; Formation of 
N-Carbethoxymonothiophthalimide (165) and N-CarCethoxydithio- 
phthalimide (166)
To a stirred suspension of N-carbethoxyphthalimide 
(2.19 g, 0.01 mol) in dry toluene Lawessons reagent (4.4 g,
1.1 eq) was added. The stirred mixture was heated at reflux 
for 8 hrs. The mixture was cooled to room temperature and 
any insoluble material removed by filtration. T.l.c. showed the 
presence of two coloured products, unreacted starting material 
and the by-product from Lawessons reagent after thionation. 
Chromatography on silica eluting with toluene yielded 
N-carbethoxymonothiophthalimide (165) as a pink solid (225 mg,
30% corrected). Further elution with toluene/petroleum ether 
(66:33) yielded N-carbethoxydithiophthalimide (166) as a olack 
solid 133 mg, 16% corrected).
N-Carbethoxymonothiophthalimide (165) (Found: 235.0303.
C.,H NO S requires 235.0317); v (CHCl ) 1760 (CO Et),
—  X1710 (CON-), 1600 (aromatic), 1320 (C=S) cm ; X (EtOH)max
327nm ( e 11,058), 288 nm (e 15,686), 231 nm (e 31,568);
6^ (60MHz:CDClg) 1.35 (3H, t, CH^), 4.35 (2H, q, OCH^), 7.60 
(4H, m, aromatic); 6 ^ (CDCl^)14.03 (CH^), 64.90 (CH^),
123.63, 124.55, 126.28, 134.14, 135.06 136.90 (aromatic),
149.30 (COOEt), 165.99 (-CON-), 192.75 (C=S); m/z 235(m ‘̂), 191, 
163, 130, 103 (base. )
N-Carbethoxydithiophthalimide (166) (Found: M^ 251.0075.
C.,H NO S requires M, 251.0056); v (CHCl ) 1740 (C=0),XX ^ 6 IDâX O
1580 (aromatic, 1370 (C=S), 1320 (-OEt) cm~^;  ̂ (EtOH)max
147.
354nm( e4,471), 242nm ( £ 3,294); (60MHz:CDCl_)H o
1.40 (3H, t, CHg), 4.47 (2H, q, CH^), 7.70 (4H, m, aromatic);
6 ^(CDClg) 13.92 (CHg), 65.93 (CHg), 123.46, 133.81, 134.46
(aromatic), 150.25 (0=0), 193.67 (C=S); m/z 251 (M^), 146 (base)
148.
N-Dlthiophthalimido phenylalanine methyl ester (166).
N-Carhethoxydithiophthalimide (85 mg, 0.34 mmol) in dry
dichloromethane (15 ml) was stirred at room temperature with
phenylalanine methyl ester hydrochloride (1 eq) and triethylamine.
The solvents were removed in vacuo to yield a olack solid.
Chromatography on silica eluting with dichloromethane/petroleum
ether (50:50) yielded two products (166) (30 mg, 31% corrected)
and the product due to initial attack oy phenylalanine methyl ester
without displacement of the amino caroethoxy ester (30 mg).
For (166) ^ (CHCl ) 2900 (CH), 1750 (CO Me), 1350 (C=S) cm"^;in&x o 6
^max (EtOH) 327nm ( E 1 ,5 3 2 ), 290nm (e 1,937), 231nm (e 4,995);
6^ (60 MHz:CDClg) 3.65 (2H, d, CH^Ph), 3.74 (3H, s, OCH^),
5.75 (IH, t, CH), 7.20 (5H, m, aromatic), 7.65 (4H, m, aromatic).
For by-product (CHCl^) 2900 (CH), 1790, 1740, 1690 (C=0),
1600 (aromatic), 1450 (OCH^), 1370 (C=S); X (EtOH)
341nm ( e 20,430), 312nm ( e 26,344), 233nm (e 39,785);
<5^ (60MHz :CDClg) 1.37 (3H, t, CH^), 3.60 (2H, d, CH^Ph),
3.72 (3H, s, OCHg), 4.30 (2H, q, CH^), 5.91 (IH, t, CH),
7.15 (5H, m, aromatic), 7.60 (4H, m, aromatic);
14.19 (CHg), 34.83 (CH^Ph), 52.5 (OCH^), 56.29 (CH), 63.06 
(OCHg), 123.52, 124.87, 125.58, 126.61, 128.17 129.31, 133.22,
136.57 (aromatics), 169.24 (C=0), 194.54 (C=S).
149.
N-Monothiophthalimido phenylalanine (167)
N-Carbethoxymonothiophthalimide (225 mg, 0.95 mmol) in water 
(25 ml) was stirred at room temperature with phenylalanine 
(175 mg, 0.96 mmol) and sodium carDonate (115 mg, 0,96 mmol).
The suspension was stirred for 5 hrs. The solution was 
extracted with dichloromethane (2 x 20 ml) and from the organic 
layer unreacted starting material (151 mg) was recovered. The 
solvent from the aqueous layer was removed in vacuo to yield a 
pink gum. Preparative thin layer chromatography on silica 
eluting with chloroform/methanol/acetic acid (90:10:1) yielded 
a pink solid (167) (50 mg, 51% corrected).
(Found: 311.0618 C^yH^gNO^S requires M, 311.0616);
V (CHCl^) 3300-2700 (CO„H), 1750, 1710 (0=0), 1600 (aromatic) max 3 2
" X1350 (C=S) cm ; 6 ^ (60MHz : CDCl^ ) 3.45 (2H, m, CH^Ph),
5.76 (IH, m, CH), 7.08 (5H m aromatic), 7.60 (4H, m, aromatic); 
6 ^ (CDCl^) 34.62 (CH^Ph), 55.76 (CH), 122.92, 124.11, 126.66,
128.29, 129.04, 133.22, 134.03, 136.57 136.74 (aromatic),
169.13 (C=0), 196.12 (C=S); m/z 311 (M*̂ ), 168, 148, 84 (base).
150.
N-Monothiophthalimido phenylalanine methyl ester (168)
N-Carhethoxymonothiophthalimide (151 mg; 0.64 mmol) in 
dry dichloromethane was stirred at room temperature with 
phenylalanine methyl ester hydrochloride (1 e q ) and triethyl­
amine (1 eq) for 5 hrs. The reaction mixture was extracted 
with water (2 x 20 ml) and 5% citric acid (2 x 20 ml). The 
organic layer was dried over magnesium sulphate, filtered and 
the solvent removed in vacuo to yield a red oil (120 mg). 
Chromatography on silica eluting with dichloromethane/ 
petroleum ether (50:50) yielded (168) (60 mg, 29%)
(Found: 325.0772 C^gH^^ON^S requires M, 325.0734);
V (CHCl^) 2900 (CH), 1710 (C=0), 1580 (aromatic), 1420ID 3.x j
—  1(OCH.^), 1320 (C=S) cm ; X (EtOH) 322nm ( e 1,200), 290nm o max
( £ 1,626), 233nm ( £4,146); 6 ̂  ( 60MHz : CDCl^ ) 3.60 (2H, d,
CHgPh), 3.73 (3H, s, OCH^), 5.70 (IH, t, CH), 7.14 (5H, m, 
aromatic),7.67 (4H, m, aromatic); 6 ̂  (CDCl^) 34.83
(CH,,Ph), 52.77 (OCH^), 55.67 (CH), 122.98, 124.22, 126.82,—  2 —  3 —
128.45, 129.15, 129.86, 133.38, 134.24, 136.63, 136.95 
(aromatic), 169.13 (C=0), 196.33 (C=S); m/z 325 (m "̂ ), 162 (base), 
131, 103.
151.
Dimethyl isovaleryl phosphonate (169)
Isovaleryl chloride (12.2 mol, 0.1 mol) was added dropwise 
to trimethyl phosphite (12.5 ml, 0.11 mol) with stirring under 
an argon atmosphere at room temperature. The reaction mixture 
was stirred at room temperature overnight. Distillation of the 
reaction mixture afforded dimethyl isovaleryl phosphonate 
(13.3 g, 69%). B.p. 108 - 111°C 5mm Hg; ^max 
2950 (CH), 1-700 (C=0), 1270 (P-OCH^), 1050 (P=0) cm"^, 5^ (60MHz:
CDClg) 0.92 (6H, d, (CH^)^), 2.20 (IH, m, CH-), 2.70 (2H, d, CH^), 
3.85 (6H, d, 12Hz, P-OCH^) ; m/z 195 (M+1), 194 (m"̂ ) , 109 
57 (base).
Isovaleryl phosphonlc acid (173)
Dimethyl isovaleryl phosphonate (1 g, 5 mmol) in dry 
dichloromethane under an argon atmosphere was treated with 
bromotrimethylsilane (2.01 ml, 15 mmol) at room temperature.
The mixture was stirred for 3 hrs and the solvent removed in vacuo 
to yield a yellow oil. This oil was treated with acetone/water 
(9:1) (10 ml) and the mixture stirred at room temperature overnight 
Solvents were removed under reduced pressure to yield a colourless 
hygroscopic oil (0.6 g, 70%) p (CHCl^) 3300-2700 (P-OH),
1710 (C=0), 1200 (P-OCHg), 1030 (P=0) cm"^; 6 ^ (60 MHz:D20)
0.94 (6H, d, (CH^)^), 2.20 (IH, m, CH-), 3.78 (2H, d, CH^CO);
6 ^ (DgO) 22.32 ((CH^)^), 23.89 and 23.99 (CH(CH^)^) 2.44 Hz),
50.71 and 52.82 (CH^COP, J^p 47.6Hz), 178.18 (0=0); m/z 166(M*), 
119 (base).
152.
g-Hydroxy- y-methylbutyl phosphonlc acid (174) .
Dimethyl isovaleryl phosphonate (1.093 g, 5.6 mmol) in 
dichloromethane (20 ml) was treated with sodium borohydride 
(0.56 g) . The mixture was stirred at room temperature for 
2 hrs. The stirred solution was diluted with water (20 ml) and 
stirred for a further 1 hr. The two layers were separated and 
the aqueous layer washed twice with dichloromethane (2 x 30 ml).
The combined organic extracts were dried over magnesium sulphate, 
filtered and the solvent removed in vacuo to yield a colourless oil 
(0.79 g, 72%).
V (neat) 3600-3200 (OH), 1220 (P-OCH.), 1050 (P=0) cmm 3  Vax
m/z 195 (M-1), 110 (base).
The dimethyl a-hydroxy-Y methylbutyl phosphonate (0.5 g,
2.55 mmol) in dry dichloromethane under an argon atmosphere was 
treated with bromotrimethylsilane (1.02 ml, 7.65 mmol) at room 
temperature. The mixture was stirred for 3 hrs and the solvent 
removed in vacuo to yield a colourless oil. This oil was treated 
with acetone/water (9:1) (10 ml) and the mixture stirred at room 
temperature overnight. Solvents were removed under reduced pressure 
to yield a white solid (0.37 g, 85%) m.p. 215-217°C; Found:
C, 33.89; H, 7.97. C^Hp^O^P.iR^O requires C, 33.80; H, 7.59%;
6 ^ (lOOMHz; (00^)280) 0.85 (6H, m, (Cïl̂ ) , 1.2-1.9 (4H, 
complex, CHCH2 and -OH), 3.60 (IH, m, CHOH), 8.58 (IH, br,
&  ((CD ) SO) 21.30 ((CH )2), 24.79 (CHCH2), 38.52 and 40.42 
(CH2CHOHP, 40.42 Hz), 61.55 and 68.75 (CHOHP, J^p 162.35Hz); 
m/z [+] ion FAB 169 (M+1) (base), 191 (M+Na); [-] ion FAB 
167 (M-1) base.
153.
Dimethyl g-oximino- y-methylbutyl phosphonate (171)
Dimethyl isovaleryl phosphonate (9.813 g, 0.051 mol) in 
ethanol (10 ml) was treated with hydroxylamine hydrochloride 
(4.6 g, 0.066 mol) and pyridine (5.6 g). The mixture was 
stirred at room temperature for 24 hrs. The solvent was removed 
in vacuo to yield a colourless oil to which 2M hydrochloric acid 
(20 ml) was added. The aqueous solution was extracted with 
dichloromethane (5 x 20 ml) and the combined organic extracts 
were washed with 2M hydrochloric acid (6 x 10 ml), water (2 x 10 ml), 
saturated sodium bicarbonate (2 x 10 ml) and water (2 x 10 ml).
The organic solution was dried over magnesium sulphate, filtered 
and the solvent removed in vacuo to yield a colourless gum 
(6 g, 56%). (neat) 3400 (OH), 2950 (CH), 1470 (C=N), 1250
(P-OCHg), 1050 (P=0) cm“^; 6^ (60MHz:CDCl^) 0.95 (6H, m, (CHg)^),
2.40 (3H, m, CHCH^), 4.08 (6H, 2d, llHz, P-OCH^); 6 ^ (CDCl^), 
22.31, 22.75 ((CH^)^), 26.38, 26.65 (CHCH^), 34.73 and 41.17 (CH^,
145.3 Hz), 34.45 and 41.93 (CH^, J^p 145.3Hz), 52.87 and 53.31 
(P-OCH^, J^p 9.77), 53.15 and 53.58 (P-OCH^, J^p 9.77Hz), 146.49 
and 153.21 (C=N, J^p 151.36Hz), 147.84 and 157.38 (C=N, J^p 214.85Hz);
6p ((00^)250), 8(M), 12(M), m/z 210 (M+1) (base), 190, 110, 84.
g -Oximino-y -methylbutyl phosphonlc acid (175)
Dimethyl a-oximino-y -methylbutyl phosphonate (2.88 g, 13.8 mmol) 
in dry dichloromethane (20 ml) was treated with bromotrimethylsilane 
(1.84 ml, 41.4 mmol) and the mixture was stirred for 3 hrs. The 
solvent was removed in vacuo to yield a colourless gum which was 
dissolved in acetone/water (9 :1) (10 ml) and the solution stirred 
at room temperature for 30 mins. Water (20 ml) was added to the
154.
mixture and the aqueous solution extracted with dichloromethane
(2 X 20 ml). The organic extracts were discarded and the water
from the aqueous solution was removed in vacuo to yield a
colourless hygroscopic gum (600 mg; 24%) 6 ^ (60MHz;D20)
0.92 (6H, d, (CH^)^), 2.11 (IH, m, CHCH^), 2.30 (2H, d, CHCH^);
6̂  (D_0) 21.32 ((CH_)_), 21.43 (CHCH_), 42.88 and 43.26 L z —  j z —  z
(CH^CP, J^p 8.55Hz), 178.42 and 180.21 (C=N); m/z (M+1) 182[ +] ion 
FAB, (M-1) 181 [ - ] ion FAB.
Dimethyl g -amino--ymethylbutyl phosphonate (172)
Dimethyl g-oximino-y -methylbutyl phosphonate (4.97 g,
23.7 mmol) in ethanol (200 ml) containing Raney nickel (3 g) was 
hydrogenated at 75 atmospheres and 100°C for 10 mins. The mixture 
was allowed to cool to room temperature and filtered through 
Celite. The solvent was removed in vacuo to yield a pale yellow
oil. Chromatography on silica eluting with chloroform/methanol 
(9:1) yielded a colourless gum (3.85 g, 85%). u 
(neat) 3450 (NH^), 2950 (CH), 1250 (P-OCH^), 1050 (P=0) cm"^,
6 ^ (100MHz:CDCl2) 0.95 (6H, m, (CH^)^), 1.55 (3H, m, CHCH^),
3.18 (IH, dt, Cffi>, Jp^ llHz), 3.80 (6H, d, P-OCH^, Jp^ llHz),
4.80 (2H, br s, NH^); 6̂  (CDCl^) 21.24, 23.30 ((CHg)2), 21.67
(CH CH^), 39.71 CHCH_), 42.74 and 49.41 (CHP, J ^ 150.15Hz),
—  Z  —  Z  —  L r
52.82 and 53.15 (P-OCH^ J 7.32), 52.98 and 53.25 (P-OÇH^,
Jgp 6.11Hz).
155.
g -Amino-y -methylbutyl phosphonlc acid
Dimethyl a-amino-Y-methylbutyl phosphonate (1 g, 5.1 mmol)
in dry dichloromethane (20 ml) was treated with bromotrimethylsilane
(0.11 ml, 20.5 mmol) and the mixture was stirred at room 
temperature for 3 hrs. The solvent was removed in vacuo to
yield a colourless gum which was dissolved in acetone/water
(9:1) (10 ml) and the solution stirred at room temperature for
30 mins. The solvents were removed in vacuo to yield a white
solid which was recrystallised from methanol-water to yield a




phosphonate dimethyl ester (176).
N-Èenzyloxycarbonyl-4-phenylalanine (3.7 g, 13 mmol) in dry 
dichloromethane (50 ml) at -23°C was treated with diphenyl 
phosphinyl chloride (DPPCl) (3.07 g, 13 mmol) and N-methylmorpholine 
(1.43 ml, 14.3 mmol). The mixture was stirred at -23°C for 
30 mins. after which dimethylot -amino-Y -methylbutyl phosphonate 
(2.54 g, 13 mmol) was added to the stirred mixture. The reaction 
mixture was allowed to warm to room temperature and stirred for 
8 hrs. The mixture was then washed with saturated sodium 
bicarbonate (2 x 20 ml), 2M hydrochloric acid (2 x 20 ml) and 
water (2 x 20 ml). The organic layer was dried over magnesium 
sulphate, filtered ̂ nd the solvent removed in vacuo to yield a pale 
yellow gum. Chromatography on silica eluting with ethyl acetate 
yielded a colourless gum (4.206 g, 70%). \nax » 3300 (NH),
2950 (CH), 1720, 1690 (C=0), 1600 (aromatic), 1250 (P-OCH^),
1050 (P=0); (60MHz: CDCl ) 0.85 (6H, m, (CH.)„), 1.45 (3H, m,
rl g  o  Z
CHCH^), 3.12 (2H, m, CH^Ph), 3.78 (6H, d, llHz) , 4.75 ( B, br, 
NH, 2 X NHCH), 5.04 (2H, s, CH^OPh), 6.05 (IH, tr, NH), 7.25 (lOH, 
m, aromatic).
157.
LyPhenylalanyl- g -amino-Y-methylbutyl phosphonlc acid (177)
N-Benzyloxycarbonyl-L-phenylalanyl- et amino-Y-methylbutyl 
phosphonate dimethyl ester (2.33 g, 5 mmol) in dichloromethane 
(10 ml) was treated with hydrogen bromide in glacial acetic 
acid (10 ml). The mixture was stirred at room temperature for 
30 mins. The solvent was removed in vacuo and the residue 
dissolved in ethyl acetate. The organic layer was washed with 
water and a gel formed in the aqueous layer. The aqueous 
solution was filtered and the gel was freeze dried to yield a 
white solid (1.23 g, 78%). m.p. 287-289°C; <5̂  (lOOMHzzD^O),
0.80 (6H, m, (CH^)^), 1.53 (3H, m, CH^CH), 3.20 (2H, m, CH^Ph), 
4.27 (IH, m, CHP), 7.31 (5H, m, aromatic); ((CD^)2S0),
20.64 ((CH^)^), 21.02 (CH^CH), 23.24 (CH^Ph), 51.42 and 52.98 
(CHP, llOHz), 127.56, 128.61, 129.31, 129.56, 134.46 
(aromatic), 169.9 (C=0); m/z (M+1) 315 [+] ion FAB, (M-1)




1. K. Prajev and J. Rachon, Z. Chem., 1975, 209; L. Maier,
Phosphorus and Sulphur, 1983, ]A, 295,
2. D, Redmore in "Topics in Phosphorus Chemistry", E.J. Griffith
and M, Grayson, eds., J. Wiley and Sons, New York,
1976, Vol. 8.
3. Methoden der Organischen Cheroie (Houoen-Weyl) E. Muller, ed;
4th Ed., Vol. 12, "Organophosphorus Compounds",
Part 1, Georg Thieme, Stuttgart, 1963.
4. M.I. Kabachnik and T. Ya. Medved, Doklady Akad, Nauk. S.S.S.R.,
1952, 84, 717, Chem. Abs., 1953, £7, 2724.
5. M.I. Kabachnik and T. Ya Medved, Doklady Akad, Nauk. S.S.S.R.,
1952, 8^, 717. Chem. Abs., 1953, 47, 3226.
6. M.E. Chalmers and G.M. Kosolapoff, J. Amer. Chem. Soc., 1953,
75, 5278.
7. E.K. Fields, J. Amer. Chem. Soc., 1952, 74, 1528.
8. K. Moedritzer and R.R. Irani, J . Org. Chem., 1966, 21» 1603.
9. R.R. Irani and K. Moedritzer, U.S. P. 3 288 846/1966.
10. D. Redmore, J. Org. Chem., 1978, 4^, 992; 996.
11. W. Szcepaniak and J. Siepak, Roczniki, Chem., 1973, 47, 929.
12. A.N. Pudovnik and I.V. Kononalova, Synthesis, 1979, 81.
13. A.N. Pudovnik, Doklady Akad. Nauk. S.S.S.R., 1952, 83, 865.
Chem. Abs., 1953, 47, 4300.
14. A.N. Pudovnik and M.V. Korchemkins, Invest, Akad. Nauk.
S.S.S.R. Otdel Khim. Nauk. S.S.S.R., 1952, 940. 
Chem. Abs., 1953, 47, 10468.
159.
15. A.N. Pudovnik, Doklady Akad. Nauk, S.S.S.R., 1953, 92, 773.
Chem Abs., 1955, 3049.
16. K. Moedritzer, Synth. Inorg. Met. Org. Chem., 1972, 2, 317.
17. R. Tyka, Tetrahedron Letters, 1970, 677.
18. R. Tyka and J. Lukzso, Synthesis, 1977, 239.
19. R. Tyka and J. Lukzso, Pol. J. Chem.,, 1978, 52, 959.
20. R. Tyka and J. Lukzso, Polish P. 99012/1978.
21. K. Issleib, K.P. Doepfer and A. Baslszuweit,
Z. Naturforsch, B. Anorg. Chem. Org. Chem., 1981,
^  B(ll), 1392.
22. E.K. Bayliss, C.D. Campbell, J.G. Dingwell and W. Pickles,
Ger. Offen., 1977, 2, 722, 162.
23. W.F. Gilmore and H.A. McBride, J. Amer. Chem. Soc., 1972,
24, 4361.
24. Von. I.e. Prasar and R. Rachon, Chem. Ber., 1975, 108, 1239.
25. H. Forster, Monatsh. Chem., 1968, 92, 380.
26. R.W. Ratcliffe and B.G. Christensen, Tetrahedron Letters.,
1973, 4645.
27. E.W. Petrillo and E.R. Spitzmiller, Tetrahedron Letters;
1979, 4929.
28. G.H. Hakimelaki and G. Just, Syn. Comm., 1980, 10, 429.
29. R.W. Ratcliffe and B.G. Christensen, Tetrahedron Letters.,
1973, 4645.
30. J, Rachon and C. Wasielewski, Z . Chem. , 1973, 13, 254.
31. J, Rachon and C. Wasielewski, Roczniki Chem., 1975, 397.
32. J. Rachon and C. Wasielewski, Tetrahedron Letters., 1978, 1609.
33. C. Wasielewski, K. Antczak and J. Rachon, Z. Chem. 1979, 19, 253
160.
34. M. Hoffman, C. Wasielewski and J. Racho.n, Ctiemica,
(Switz. ), 1976, 30, 187.
35. J. Rachon and C. Wasielewski, Roczniki Chem., 1976, 50» 477.
36. C. Wasielewski, K. Antczak and J. Rachon, Pol. J . Chem. ,
1978, 52, 1315.
37. J. Oleksyszyn, M. Soroka and J. Rachon, Chimica, 1978, 32, 253.
38. D, Redmore, P. 533 within reference; .
39. A. Kotynski and W.J. Stec, Pol. J . Chem. , 1978, 52, 659.
40. A. Kotynski and W.J. Stec, J. Chem. Res.(S), 1978, 41.
41. A. Vasella and R. Voeffray, Helv. Chim. Acta., 1982, 65(7), 1953,
42. J.I.G. Cadogan, J . Chem. Soc., 1957, 4154.
43. M.E. Duggan and D.S. Karenewsky, Tetrahedron Letters., 1983,
2i, 2935.
44. A.J. Kirby and S.G. Warren, "The Organic Chemistry of
Phosphorus", Elsevier, Amsterdam, 1967.
45. R.G. Harvey and R.G. DeSombre in "Topics in Phosphorus
Chemistry", E.J. Griffiths and M. Grayson eds.,
Wiley. Interscience, New York, 1964, Vol. 1.
46. I.e. Popoff, L.K. Huber, B.P. Block, P.D. Morton and
R.P. Riordan, J. Org. Chem., 1963, 28, 2898.
47. M.I. Kabachnik and P.A. Rosiiskaya, Bull, acad. Sci. U.R.S.S.,
Classe sci. chim., 1945, 364. Chem. Abs., 1946,
£0, 4688.
48. G.M. Kossolapoff, J. Amer. Chem. Soc., (a) 1947, 69, 2112;
(d ) 1948, 70, 1283.
49. (a) K. D. Berlin, R.T. Claunch and E.T. Gaudy, Abstracts 155th
National Meeting of the American Chemical Society,
San Francisco, California, April 1968.
(b) K.D. Berlin, R.T. Claunch and E.T. Gaudy, J. Org. Chem., 
1968, 33, 3090.
161.
50. K.D. Berlin, N.K. Roy, R.T. Claunch and D. Bude,
J. Amer. Chem. See., 1968, 4494.
51. S.Asano, T. Kitatiara, T. Ogawa, M. Matsui, Agric. and Biol.
Chem. (Japan), 1973, 3T_, 1193.
52. Z.H. Kudzin and A. Kotynski, Synthesis, 1980, 1028.
53. J.R. Chambers and A.F. Isbell, J . Org. Chem., 1964, 832.
54. M. Soroka and P. Mastalerz, Roczniki Chem., 1976, 661.
55. G. Opitz, A. Gressinger and H.W. Schubert, Annalen., 1963,
665, 91.
56. W.J. Stec, K. Lesiak and M. Sudol, Synthesis. , 1975, 785.
57. W.J. Stec and K. Lesiak, J. Org. Chem., 1976, 41̂ , 3757.
58. M.M. Sidky, F.M. Soliman and R. Shabana, Tetrahedron, 1971,
27. 3431.
59. M. Vaultier, M.S. Ovali and R. Carrie, Bull. Soc. Chim. France.,
1978, (11), 343.
60. M.M. Campbell and N.I. Carruthers, J. Chem. Soc. Chem. Commun.,
1980, 730.
61. M.M. Campbell, N.I. Carruthers and S.J. Mickel, Tetrahedron,
1982, æ ,  2513.
62. J. Oleksyszyn and L. Subdsotkowska, Synthesis, 1980, 906.
63. T. Shono, Y. Matsumura and K. Tsubata, Tetrahedron Letters,
1981, 3249.
64. (a) J.R. Chambers and A.F. Isbell, J . Org. Chem., 1964, 2^, 832.
(b) J.P. Berry, Ph.D Thesis, Texas A and M. University, 1963.
Piss. Abs., 1964, 2A, 3974.
(c) J.P. Berry, A.F. Isbell and G.E. Hunt, J. Org. Chem., 1972,
37, 4396.
162.
65. S.F, Chen, S.D. Kumar and M. Tischler, Tetrahedron Letters.,
1983, 24, 5461.
66. J. Rachon, C. Waskielewski and A. Sohczak, Z . Chem., 1974,
]A, 152.
67. M. Soroka and P. Mastalerz, Tetrahedron Letters., 1973, 5201.
68. (a) M. Engelmann and J. Plkl, U.S. P. 2 304 156/1942;
(b) M. Engelmann and J. Pikl, U.S.P. 2 304 157/1942;
(c) J. Pikl, U.S.P. 2 328 358/1943.
69. J. Oleksyszyn, R. Tyka and P. Mastalerz, Synthesis, 1978, 479
70. W. Suhotowski, R. Tyka and P. Mastalerz, Pol. J. Chem., 1980.
503.
71. J. Oleksyszyn, Synthesis., 1980, 722.
72. J. Oleksyszyn and E. Gruszecka, Tetrahedron Letters., 1981,
3537.
73. F. Kruger and L. Bauer, Ger Offen., 2 013 371/1972.
74. F. Kruger, L. Bauer and W. Michael, U.S.P., 3 796 749/1974.
75. F. Kruger and L. Bauer, Chem. Ztg., 1972, £6, 691.
76. W. Szczepaniak and K. Kuczynski, Phosphorus and Sulphur.,
1979, 7, 333.
77. K. Sommer and G. Raah, Ger. Offen, 2 829 046/1978.
78. G. Birum, J . Org. Chem., 1974, 209.
79. J.W. Huber and M. Middlebrooks, Synthesis, 1977, 883.
80. J.W. Huber and W.F. Gilmore, Tetrahedron Letters, 1979, 3049,
81. Z.H. Kudzin and W.J. Stec, Synthesis, 1978, 469.
82. Z.H. Kudzin and W.J. Stec, Synthesis, 1980, 1032.
83. Z.H. Kudzin, Synthesis, 1981, 643.
84. Z.H. Kudzin and W.J. Stec, Synthesis, 1983, 812.
163.
85. C.C. Tam, K.L. Mattocks and M, Tischler, Synthesis, 1982, 188,
86. J, Oleksyszyn, L. SuDotkowska and P. Mastalerz, Synthesis,
1979, 985.
87. J, Oleksyszyn and R. Tyka, Tetrahedron Letters., 1977, 2823.
88. G.M. Kosolapoff, J. Amer. Chem. Soc., 1947, 6^, 2112.
89. M.I. Kabachnik and T. Ya Medved, Izvest, Akad. Nauk. S.S.S.R.,
Otdel. Khim. Nauk., 1950, 635. Chem. Ahs., 1951,
45, 8441.
90. M.I. Kabachnik and T. Ya Medved, Izvest. Akad. Nauk. S.S.S.R.,
Otdel. Khim. Nauk. 1951, 95. Chem. Abs., 1952, 46. 
421.
91. T. Ya Medved, Khim. i. Primenie Fosfororgen Soedinenii Akad.
Nauk. S.S.S.R., Trudy 1-01 Konferents., 1955 
(publ. 1957), 262. Chem. Abs. , 1958, 253.
92. S. Westerback, K. S. Rajan and A.E. Martell, J. Amer. Chem. Soc.,
1965, 2567.
93. W.M. Ramsey and C. Kezerian, U.S. P. 2 917 528/1959. Chem. Abs.,
1960, 24399.
94. P.G. Baraldi, M. Guarneri, F, Moroder, G.P. Follini and
D. Simoni, Synthesis., 1982, 653.
95. F. Texierboullet and A. Foucaid, Synthesis., 1982, 916.
96. A.M. Lacoste, A. Cassaigne and E. Neuzil, C.R. Acad. Sc.
Paris, Ser. P., 1972, 275, 3009. Chem. Abs., 1973,
78, 124854.
97. P. Mastalerz, Acta. Biochimica. Polonica., 1957, 19.
98. H. Gross and T. Gnauk. J. Prakt. Chem., 1976, 318, 157.
99. E. Gruzecka, M. Soroka and P. Mastalerz, Pol. J. Chem., 1979,
53, 937.
164.
100. E. Gruzecka, P. Mastalerz and M. Soroka, Roczniki Chem.,
1975, 2127.
101. P. Mastalerz, Roczniki Chem., 1959, 985.
102. V. Chevane, Compt, Rend., 1947, 224, 919.
103. V. Chevane, Bull. Soc. Chim. France., 1948, 774.
104. L.F. Englert, Ph.D. Thesis, Texas A and M University, 1969,
Diss. Abs. Int. B ., 1970, 4970.
105. These compounds are reported available from Calibochem,
Los Angeles, California; see also J. Le Pogan,
H. Jensen and E. Neuzil, J. Chromatog., 1973, ST_, 179
106. P. Kafarski, B. Lejczak and J. Szewczyk, Can. J . Chem., 1983,
61, 2425.
107. F.H. Holtkamp, Ph.D. Thesis, Texas A and M University, 1969,
Diss. Abs. Int. B., 1970, 31, 119.
108. A. Dehnel and G. Levielle, Bull. Soc. Chim. France, 1978,
(II), 95.
109. J. Zygmunt and P. Mastalerz, Pol. J. Chem., 1978, 2271;
1981, 411.
110. J. Lukszo, J. Kowalik and P. Mastalerz, Chem. Lett., 1978, 1103,
111. T. Glowiak, W. Dobrowdska, J, Kowalik, P. Mastalerz,
M. Soroka and J. Zon, Tetrahedron Letters, 1977,
3965.
112. G.L. Rowley, A.L. Greenleaf and G.L. Kenyon, J. Amer. Chem.
Soc., 1 9 7 1 , 5 5 4 2 .
113. K. Issleib, K.P. Dopfer and A. Balszwert, Z. Chim., 1982, 22,
215.
165.
114. (a) M.Okuhara, Y Juroda, T, Goto, M. Okamoto, H, Terano,
M. Kohsaka, H,. Aoki and H, Imanaka, J . Antibiot. ,
1980, 13.
(b) E. Iguchi, M. Okuhara, M. Kohsaka, H, Aoki and H, Imanaka,
J. Antioiot., 1980, 18.
(c) M. Okuhara, Y, Kuroda, T. Goto, M. Okamoto, H. Terano,
M. Kohsaka, H. Aoki and H, Imanaka, J. Antibiot.,
1980, ^ , 2 4 .
(d) Y. Kuroda, M. Okuhara, T. Goto, M. Okamoto, H. Terano,
M. Kohsaka, H. Aoki and H. Imanaka, J. Antibiot. , 1980,
29.
(e) Y. Mine, T. Kamimura, S. Nonoyama, M. Nishida, S. Goto,
and S. Kuwahara, J. Antibiot., 1980, 33, 36.
(f) H. Kojo, Y. Shigi and M. Nishida, J . Antibiot. , 1980, 33,
44.
(g) Y. Kuroda, T. Goto, M. Okamoto, M. Yamashita, E. Iguchi,
M. Kohsaka, H. Aoki and H. Imanaka, J. Antibiot. ,
1980, 33, 272.
115. T. Kamiya, K. Hemni, H. Takeno and M. Hashimoto,
Tetrahedron Letters, 1980, 95; 99.
116. T. Ogita, S. Gunji, Y. Fukazawa, A. Terahara, T. Kimoshita
and H. Nagaki, Tetrahedron Letters, 1983, 2283.
117. (a) D. Hendlin, E.O. Stapley, M. Jackson, H. Wallick,
A.K. Miller, F.J. Wolff, T.W. Miller, L. Chaiet,
F.M. Kahan, E.L. Foltz, H.B. Woodruff, S. Hernandez 
and S. Mochales, Science, 1969, 166, 122.
(b) E.G. Christensen, W.J. Leanza, T.R. Beattie, A.A. Patchett,
B.H. Arison, E. Ormond, F.A. Kuehl, G. Albers- 
Schonberg and O. Jardetzky, Science, 1969, 166, 123.
166.
(c) E.J. Glamkowski, G. Gai, R. Purick, A.J. Davidson and 
M. Sletzinger, J . Org. Chem., 1970, 3510.
118. B.G. Christensen and T.R. Beattie, Ger. P. 2011 092/1970,
Chem. Abs., 1971, 74, 42491.
119. D.L. Pruess, J.P. Scannell, H.A. Ax, M. Kellett, F. Weiss,
T.C. Demny and A. Stempel, J . Antibiot., 1973, 261.
120. K. D. Collins and G.R. Stark, J. Biol. Chem., 1971, 246, 6599.
121. R. K. Johnson, T. Inouye, A. Goldin and G.R. Stark, Cancer
Research, 1976, 2720.
122. Y. Okamoto, 1st International Congress on Phosphorus
Compounds, Rabat, 1977, Proceedings, p. 649.
123. E.G. Jaworski, J . Agr. Food. Chem., 1972, 1195.
124. U. Roisch and F. Lingens, Angew. Chem. Int. Ed., 1974, 1^, 400.
125. Drugs of the Future, 1979, 4, 783.
126. T.R. Herrin, J.S. Fairgrieve, R.R. Bower, N.L. Shipkowitz
and J.C. Mao, J . Med. Chem., 1977, 20, 660.
127. J.J. Yaounac, G. Sturtz, J.L. Kraus, C. Chastel and J. Colin,
Tetrahedron Letters, 1980, 2689.
128. B.K. Park, A. Hirota and H. Sakai, Agric. Biol. Chem., (Japan),
1977, 573.
129. H. Diddens, M. Dorgerloh and H. Zahner, J. Antibiot., 1979, 32,
87.
130. K. Totsukawa, T. Suzuki, C. Moriyama, J. Yoshida S. Inouye
and T. Niida, Sci. Rep. Meiji Seika Kaisha, 1973, 34;
Y. Ogawa, T. Tsuruoka, S. Inouye and T. Niida, ibid.,
1973, 42; Y. Ogawa, H. Yoshida, S. Inouye and T. Niida,
ibid. , 1973, 49; Y. Ogawa, H. Yoshida, S. Inouye and
T. Niida, ibid., 1973, 554; N. Ezaki, S. Amano,
K. Fukushima, S. Inouye and T. Niida, ibid., 1973, 60.
167.
131. (a) E, Bayer, K.H. Gugel, K. Hagele, H, Hagenmaier,
S. Jessipow, W.A. Konig and H, Zahner, Helv. Chim.
Acta. , 1972, 224.
(b) E. Gruszecka, M. Soroka and P. Mastalerz, Pol. J . Chem., 
1979, M ,  937.
132. H. Gross. T. Gnauk, J. Prakt. Chem., 1976, 318, 157.
133. E. Gruszecka, P. Mastalerz and M. Soroka, Roczniki Chem.,
1975, 397.
134. N. Minowa, S. Fukatu, T. Niida, M. Takada and K. Sato,
Tetrahedron Letters, 1983, 2391.
135. J.G. Allen, F.R. Atherton, M.J. Hall, C.H. Hassall, S.W. Holmes,
R.W. Lamber, L.J. Nisbet and P.S. Ringrose, Nature,
1978, 272, 56.
136. F.R. Atherton, M.J. Hall, C.H. Hassall, R.W. Lambert,
W.J. Floyd and P.S. Ringrose, Antimicrob. Agents, 
Chemother., 1979, ]^, 696.
137. J.G. Allen, F.R. Atherton, M.J. Hall, C.M. Hassall, S.W. Holmes,
R.W. Lambert, L.J. Nisbett and P.S. Ringrose, 
Antimicrob. Agents. Chemother., 1979, 684.
138. S. Umezawa, K. Tatsuta and 0. Izawa, Tetrahedron Letters,
1972, 97.
139. L.H. Weaver, W.R. Kester and B.W. Matthews, Mol. Biol., 1977,
114, 119.
140. C.M. Kam, N. Nishino and J.C. Powers, Biochemistry, 1979, 18,
3032.
141. K. Yamauchi, M. Kinoshita and M. Imoto, Bull. Chem. Soc. Jpn.,
1972, 2528.
142. M, Hariharan, S. Chaberek and A.E. Martell, Syn. Commun., 1973,
3(5), 375.
168.
143. H.E. JacoDsen and P.A. Bartlett, J. Amer. Chem. Soc., 1981,
103, 654.
144. K. Yamauchi, Y. Mitsuda and M. Kinoshita, Bull. Chem. Soc. Jpn.,
1975, ^(11), 3285.
145. K. Yamauchi, S. Ohtsuki and M. Kinoshita, J . Org. Chem., 1984,
1158.
146. W.J. Greenlee, A.A. Patchett, E.E. Harris and E.D. Thorsett,
Eur. P. 0 058 427/1982.
147. D.S. Karanewsky and E. Petrillo, Eut. P. 0 083 172/1982.
148. (a) D.J. Mayer and J.C. Liebeskind, Brain Res., 1974, 68, 73.
(b) J.C. Liebeskind, D.J. Mayer and H. Akil, Advan. Neurol.,
1974, 4, 261.
149. H. Akil, D.J. Mayer and J.C. Liebeskind, Science, 1976, ]^, 961,
150. J. Hughes, Brain Res., 1975, 295.
151. (a) L. Terenius and W. Wahlstrtira, Acta. Physiol. Scand., 1975,
74.
(b) J. Hughes, T.W. Smith and H.W. Kosterlitz, Nature, 1975, 
.-fcrVhor̂ MI ̂ W fZ. MORRIS.
258, 577.
152. G.W. Pasternak, R. Goodman and S.H. Synder, Life Sci. , 1975, 16,
1765.
153. J.M. Polak, S.N. Sullivan, S.R. Bloom, P. Facer and
A.G.E. Pearse, Lancet, 1977, 1, 972.
154. B. Malfroy, J.P. Swerts and A. Grayon, Nature, 1978, 276, 523.
155. T.W. Smith, J. Hughes and H.W. Kosterl'i’z in Opiates and
Endogenous Opioid Peptides, H.W. Kosterlerz, ed. North-
Holland, Amsterdam, 1976, p. 57.
156. L.A.H. Lord, A.A. Waterfield and J. Hughes, Nature, 1977, 269^
495 .
169.
157. A.R. Day, M. Lujan, W.L. Dewey, L.S. Harris, J.A. Radding
and R.J. Freer, Res. Commun. Pathol. Pharmacol.,
1976, lA, 597.
158. A. Goldstein, J. Goldstein and B.M, Cox, Life Sci., 1975, 17,
1643.
159. H.H. Büscher, R.C. Hill, D. Rdmer, F. Cardineaux, A. Closse,
D. Hauser and J. Pless, Nature, 1976, 261, 423.
160. A.S. Horn and J.R. Rodgers, J. Pharm. Pharmacol., 1976, 29
257.
161. A.P. Feinberg, I. Cresse arad S.H. Snyder, Proc. Natl. Acad.
Sci. U.S.A., 1976, 73, 4215.
162. F.A. Gorin and G.R. Marshall, Proc. Natl. Acad. Sci. U.S.A.,
1977, 74, 5179.
163. A.F. Bradbury, D.G. Smyth and C.R. Snell, Nature, 1976, 260,
165.
164. H.E. Boshard, C.D. Barry, J.M. Fritsch, R.A. Ellis and
G.R. Marshall, Proc. 1972 Summer Simulation Conf.,
1972, 1, 58.
165. G.R. Marshall and H.E. Bossard, Circ. Res., 1972, 31(11), 30;
43.
166. F.A. Gorin, T.M. Balasubramanian, T.J. Cicero, J. Schwietzer
and G.R. Marshall, J. Med. Chem., 1980, 1113.
167. J.S. Morley, Ann. Rev. Pharmacol. Toxicol., 1980, 81.
168. S. Bajusz, A.Z. Ronai and J.I. Szekezy, Febs. Letts., 1980, 117,
308.
170.
169. J.C. Schwartz, B. Malfroy and S. De La Baume, Life Sci.,
1981, 1715.
170. J.A. Hartsuck and W.N. Liscomb,. in "The Enzymes",
P.D. Boyer, ed.. Academic Press, New York, 
1977, Vol. 3.
171. W.N. Liscomb, Tetrahedron, 1974, 30, 1725.
172. (a) R. Breslow and D.L. Wernick, Proc. Natl. Acad. Sci.
U.S.A., 1977, 74, 1303.
(b) W.R. Kester and B.W. Matthews, Biochemistry, 1977,
16 y 2506.
(c) D.S. Auld and B. Holmquist, Biochemistry, 1974, 13,
4355.
173. J. Suh and E.T. Kaiser, Biochem. Biophys. Res. Commun.,
1975, # ,  863.
174. P.A. Bartlett, J.T. Hunt, J.L. Adams and J.C.E. Gehert,
Bioorg. Chem., 1978, 7̂, 421.
175. A.G. Jackson, G.W. Kenner, G.A. Moore, R. Ramage
and W.D. Thorpe, Tetrahedron Letters, 19 76, 
3627.
176. N.E. Jacobsen and P.A. Bartlett, J. Amer. Chem. Soc.,
1983, 105, 1613.
177. For an exhaustive compilation, see T.W. Greene,
"Protective groups in Organic Chemistry". 
Wiley-lnterscience, New York, 1981,
Ch. 7 and references therein.
171.
178. I. Schumann and R.A. Boissonas, Helv. Chim. Acta., 1952,
35, 2235.
179. J.O. Osby, M.G. Martin and B. Ganem, Tetrahedron Letters,
1984, 2093.
180. Pol. P 206980/1978.
181. B. El Amin, G.M. Anantharamaiah, G.P. Royer and G.E. Means,
J. Org. Chem., 1979, # ,  3442.
182. J.A. Montgomery and H.J. Thomas, J. Org. Chem., 1965, 30,
3235.
183. B. Moreau, S. Laville and A. Marquet, Tetrahedron Letters,
1977, 2591.
184. S. Shabana, S. Scheibye, K. Clausen, S.O. Olesen and
S.O. Lawesson, Nouv. J. Chem., 1980, 47.
185. S. Asano, T. Kitahara, T. Ogawa and M. Matsui,
Agric. Biol. Chem., 1973, 37(3), 1193.
186. C.E. McKenna, M.T. Higa, Neil H. Cheung and M-C McKenna,
Tetrahedron Letters, 1977, 155.
